intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
placebo,128,164,13,326,54,685
standard care,26,70,3,77,12,188
hydroxychloroquine,16,33,5,37,30,121
convalescent plasma,13,42,2,46,6,109
saline,12,14,1,24,0,51
ivermectin,1,20,0,22,1,44
remdesivir,5,15,0,22,2,44
azithromycin,7,9,2,17,6,41
tocilizumab,7,12,0,16,5,40
mesenchymal stem cells,8,10,0,15,0,33
ritonavir,2,7,2,20,1,32
favipiravir,7,10,0,14,0,31
blood sample,4,3,0,21,1,29
dexamethasone,3,3,0,17,4,27
lopinavir,2,5,2,15,1,25
vitamin d,4,5,1,12,3,25
exercise,1,9,1,13,0,24
colchicine,1,6,0,13,2,22
oxygen,6,2,0,11,3,22
control,2,5,0,10,4,21
enoxaparin,0,6,0,13,2,21
lopinavir/ritonavir,2,5,2,11,1,21
prone positioning,2,7,0,12,0,21
methylprednisolone,0,9,0,11,0,20
nitazoxanide,2,7,0,9,2,20
heparin,1,6,1,11,0,19
chloroquine,1,7,0,4,6,18
interferon,1,5,1,11,0,18
vitamin c,1,5,0,11,1,18
questionnaire,1,2,1,13,0,17
plasma,3,7,0,4,2,16
camostat mesilate,1,2,0,10,2,15
serology test,2,2,1,10,0,15
anakinra,3,3,0,4,4,14
bcg,6,1,0,6,0,13
bnt162b2,3,1,0,9,0,13
telehealth,2,4,0,7,0,13
baricitinib,2,3,0,6,1,12
zinc,0,3,1,8,0,12
ad26.cov2.s,6,0,0,5,0,11
hydroxychloroquine / azithromycin,3,4,2,1,1,11
radiotherapy,1,2,0,7,1,11
ruxolitinib,0,5,0,2,4,11
best available therapy,0,5,0,5,0,10
mrna-1273,6,0,0,4,0,10
rivaroxaban,1,2,0,6,1,10
saliva,3,3,0,3,0,9
biological samples,1,3,0,4,0,8
inactivated sars-cov-2 vaccine,4,0,2,2,0,8
losartan,0,5,0,3,0,8
nitric oxide,7,1,0,0,0,8
sarilumab,2,4,0,1,1,8
vaccine,0,0,0,8,0,8
cholecalciferol,0,2,0,5,0,7
gam-covid-vac,4,2,0,1,0,7
mindfulness,0,2,1,4,0,7
rapid test,1,2,1,3,0,7
therapeutic plasma exchange (tpe),0,5,0,2,0,7
adenovirus type 5 vector,2,1,0,3,0,6
apixaban,1,1,0,4,0,6
azd1222,3,0,0,3,0,6
azd7442,4,0,0,2,0,6
blood test,0,2,0,4,0,6
cellectraâ® 2000,4,0,0,2,0,6
clazakizumab,1,3,0,2,0,6
coronavac,2,0,0,4,0,6
lenzilumab,3,1,0,2,0,6
melatonin,0,1,0,5,0,6
n-acetylcysteine,1,2,0,2,1,6
nafamostat mesilate,1,2,0,3,0,6
niclosamide,1,0,0,5,0,6
oseltamivir,1,0,0,5,0,6
peginterferon,2,1,0,3,0,6
povidone/iodine,0,4,0,2,0,6
pulmozyme,0,0,0,6,0,6
regn10933,3,1,0,2,0,6
regn10987,3,1,0,2,0,6
sofosbuvir,0,3,0,3,0,6
,0,3,1,1,0,5
ampion,1,1,0,3,0,5
arbidol,1,2,0,2,0,5
aspirin,1,0,1,3,0,5
atorvastatin,0,1,0,4,0,5
bamlanivimab,1,2,0,2,0,5
best supportive care,0,2,0,2,1,5
budesonide,0,2,0,2,1,5
ciclesonide,0,2,0,2,1,5
doxycycline,0,3,0,2,0,5
famotidine,2,1,0,1,1,5
fluvoxamine,1,1,0,3,0,5
ly3819253,2,2,0,1,0,5
nasopharyngeal swab,1,1,0,3,0,5
nk cells,2,0,0,3,0,5
pcr,1,1,0,3,0,5
quercetin,0,3,0,2,0,5
sargramostim,0,2,0,3,0,5
supportive care,1,3,0,1,0,5
telmisartan,0,1,0,4,0,5
vir-7831,2,1,0,2,0,5
acalabrutinib,1,2,0,0,1,4
anticoagulation,2,0,0,1,1,4
bacille calmette-guã©rin (bcg),0,0,0,4,0,4
biological,1,1,0,2,0,4
blood,2,1,0,1,0,4
bromhexine hydrochloride,1,1,1,1,0,4
chadox1,3,0,1,0,0,4
corticosteroid,0,0,0,4,0,4
ct-scan,0,1,0,3,0,4
cyclosporine,1,1,0,2,0,4
daclatasvir,0,1,0,3,0,4
defibrotide,1,0,0,3,0,4
emtricitabine,0,3,0,1,0,4
high flow nasal cannula,0,2,0,2,0,4
inactivated vaccine,1,1,0,2,0,4
information,3,0,0,1,0,4
kg,0,1,0,2,1,4
mavrilimumab,0,2,0,2,0,4
mesenchymalÂ stem cells,0,1,0,3,0,4
methylene blue,0,1,0,3,0,4
mvc-cov1901(s protein with adjuvant),2,0,1,1,0,4
na-831,0,0,2,2,0,4
paracetamol,1,1,0,2,0,4
pf-07321332,0,0,0,4,0,4
phone call,2,1,0,1,0,4
pirfenidone,0,0,0,4,0,4
probiotic,0,1,0,3,0,4
proxalutamide,1,2,0,1,0,4
pulmonary rehabilitation,0,0,1,3,0,4
sars-cov-2 rs,3,0,0,1,0,4
sodium,0,0,0,4,0,4
survey,0,1,0,3,0,4
ace inhibitor,0,1,0,2,0,3
acupressure,0,0,2,1,0,3
adsorbed covid-19 (inactivated) vaccine,3,0,0,0,0,3
allocetra-ots,1,0,0,2,0,3
asbrip,1,2,0,0,0,3
at-527,0,0,0,3,0,3
atazanavir,0,0,0,3,0,3
av-covid-19,0,2,0,1,0,3
ayurveda,0,3,0,0,0,3
bevacizumab,0,1,0,1,1,3
blood donation sms,0,1,2,0,0,3
bnt162b1,1,0,0,2,0,3
brii-196,0,0,0,3,0,3
brii-196/brii-198,0,0,0,3,0,3
brii-198,0,0,0,3,0,3
canakinumab,0,3,0,0,0,3
cannabidiol,2,0,0,1,0,3
chloroquine/hydroxychloroquine,0,1,0,2,0,3
clopidogrel,0,1,0,2,0,3
comirnaty,2,0,0,1,0,3
cpap,1,0,0,1,1,3
cvncov vaccine,3,0,0,0,0,3
data collection,1,1,0,1,0,3
distilled water,0,1,0,2,0,3
education,0,1,1,1,0,3
eidd-2801,0,2,0,1,0,3
ensovibep,0,1,0,2,0,3
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),2,1,0,0,0,3
experimental group,1,1,0,1,0,3
fisetin,0,0,3,0,0,3
fostamatinib,0,1,0,2,0,3
had5-s-fusion,2,0,0,1,0,3
honey,0,1,0,2,0,3
hyperbaric oxygen,0,0,0,2,1,3
hzvsf-v13,0,1,0,2,0,3
igg,0,1,0,2,0,3
imdevimab,0,0,0,3,0,3
immunoglobulin,0,2,0,1,0,3
infliximab,0,1,0,2,0,3
ino-4800,2,0,0,1,0,3
interleukin,0,0,0,3,0,3
leflunomide,1,0,0,2,0,3
low,1,0,0,2,0,3
ly3832479,2,1,0,0,0,3
maraviroc,0,1,0,2,0,3
meditation,1,1,1,0,0,3
moderna covid-19 vaccine,1,0,0,2,0,3
molnupiravir,0,0,0,2,1,3
naltrexone,0,0,1,1,1,3
nasal rinse,0,0,0,3,0,3
physical therapy,2,1,0,0,0,3
prednisone,0,1,0,0,2,3
ravulizumab,0,0,0,2,1,3
regn10933 / regn10987,2,0,0,1,0,3
regn10933/regn10987 combination therapy,1,1,0,1,0,3
resveratrol,1,0,0,1,1,3
ribavirin,0,1,0,1,1,3
sevoflurane,0,1,0,1,1,3
sirolimus,0,0,0,3,0,3
sng001,1,0,0,2,0,3
splenic ultrasound,0,1,1,1,0,3
surgical mask,0,3,0,0,0,3
suspension of heat killed (autoclaved) mycobacterium w,0,1,0,2,0,3
tofacitinib,0,2,0,1,0,3
transcranial direct current stimulation,0,0,0,3,0,3
ub-612,0,1,0,2,0,3
vitamin super b-complex,2,1,0,0,0,3
viusid,1,2,0,0,0,3
vla2001,2,0,0,1,0,3
vpm1002,3,0,0,0,0,3
water,0,1,0,0,2,3
[18f]f-arag (2'-deoxy-2'-fluoro-9-î²-d-arabinofuranosylguanine),0,0,0,2,0,2
1 âµg cov2 sam (lnp),2,0,0,0,0,2
100 mg,0,1,0,1,0,2
18f-î±vî²6-bp,0,0,2,0,0,2
202-cov low adjuvant dose,0,0,0,2,0,2
202-cov low antigen dose,0,0,0,2,0,2
202-cov standard dose,0,0,0,2,0,2
28-day schedule,0,0,1,1,0,2
99mtc-pertechnetate aerosol,0,2,0,0,0,2
aã§aã­ palm berry extract - natural product,0,0,0,2,0,2
abatacept,1,0,0,1,0,2
acebilustat,0,0,0,2,0,2
acetylsalicylic acid,0,1,0,1,0,2
active placebo,0,0,0,2,0,2
adg20,0,0,0,2,0,2
adjuvant,1,0,0,1,0,2
advax-sm adjuvant,1,0,0,1,0,2
aeonose,0,2,0,0,0,2
ambrisentan,0,0,0,2,0,2
"anti-covid19 mrna-based vaccine (bnt162b2, comirnatyâ®, commercialized by pfizer)",0,0,0,2,0,2
arb,0,0,0,2,0,2
artecomâ® (pyronaridine-artesunate),0,0,0,2,0,2
artesunate,0,1,0,1,0,2
avdoralimab,1,1,0,0,0,2
avigan,1,0,0,1,0,2
aviptadil,0,1,0,1,0,2
aviptadil 67î¼g,0,0,0,2,0,2
bat,0,0,0,1,1,2
behavior,0,0,0,2,0,2
behavioral,0,0,1,0,1,2
bioargininaâ®,0,0,0,2,0,2
blood draw,0,0,0,2,0,2
brequinar,0,2,0,0,0,2
broncho-vaxomâ®,2,0,0,0,0,2
canine odor detection of volatile organic compounds,0,1,0,1,0,2
caring contacts,1,0,1,0,0,2
casirivimab,0,0,0,2,0,2
cellectraâ„¢ 2000,0,0,0,2,0,2
cenicriviroc,0,0,0,2,0,2
chest ct,0,1,0,1,0,2
clevudine,0,0,0,2,0,2
clorhexidine dental phbâ©,0,2,0,0,0,2
colgate periogardâ® mouthwash,0,0,2,0,0,2
colgate peroxylâ® -1.5% hydrogen peroxide,0,0,0,2,0,2
colgate peroxylâ® mouthwash,0,0,2,0,0,2
colgate totalâ® mouthwash,0,0,2,0,0,2
conjunctival swab,0,1,0,1,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",0,0,0,2,0,2
conventional oxygen therapy,1,1,0,0,0,2
corsodylâ® alcohol free -0.2 % chlorhexidine digluconate,0,0,0,2,0,2
covi-amg,0,0,0,2,0,2
coviage,0,2,0,0,0,2
covid-19 patients,1,0,0,1,0,2
covid-viroâ® test,0,2,0,0,0,2
ct-p59,1,0,0,1,0,2
curosurfâ® (poractant alfa),0,0,0,2,0,2
cvncov 12 î¼g,2,0,0,0,0,2
cvncov 12î¼g,2,0,0,0,0,2
cvncov 6 î¼g,2,0,0,0,0,2
cyt107,0,0,0,2,0,2
cytokine adsorption,0,1,0,1,0,2
cytosorb,0,1,0,1,0,2
d,0,1,0,1,0,2
dalargin,0,1,0,1,0,2
dapagliflozin,0,1,0,1,0,2
"ddropsâ® products, 50,000 iu, oral",0,0,0,2,0,2
dipyridamole,0,1,0,1,0,2
disulfiram,1,0,0,1,0,2
dose)- stage 2,2,0,0,0,0,2
dose) - stage 1,2,0,0,0,0,2
dose) - stage 2,2,0,0,0,0,2
drã¤ger antigen test sars-cov-2,0,0,0,0,2,2
duvelisib,0,0,0,2,0,2
dwrx2003,0,0,0,1,1,2
dzif-10c,1,1,0,0,0,2
ðžxygen therapy,0,0,0,2,0,2
ebselen,0,0,2,0,0,2
ec-18,0,0,0,2,0,2
ecg,1,0,0,1,0,2
edp1815,0,0,0,2,0,2
entrã©e: behavioral skills,0,2,0,0,0,2
entrã©e: cognitive skills,0,2,0,0,0,2
entrã©e: interpersonal skills,0,2,0,0,0,2
escola l'horitzã³,0,2,0,0,0,2
essential oils,0,1,0,1,0,2
exo 1,0,1,1,0,0,2
exo 2,0,1,1,0,0,2
extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,0,0,0,2,0,2
favipiravir / standard care,0,1,0,1,0,2
favipiravir/hydroxychloroquine,1,1,0,0,0,2
fit test,0,2,0,0,0,2
folic acid,1,0,0,1,0,2
fotv,0,0,0,2,0,2
fultiumâ® -d3 800,0,0,0,2,0,2
fuzheng huayu,0,1,0,1,0,2
gam-covid-vac / gam-covid-vac,0,1,0,1,0,2
gammacoreâ® (vagus nerve stimulation),2,0,0,0,0,2
gammacoreâ® sapphire (non-invasive vagus nerve stimulator),2,0,0,0,0,2
gargle,0,0,0,2,0,2
glycine,0,0,0,2,0,2
grad-cov2,1,1,0,0,0,2
gx-19n,1,0,0,1,0,2
gx-i7,0,0,0,2,0,2
had5-s-fusion/n-etsd vaccine,1,0,0,1,0,2
health supplements,0,0,0,2,0,2
hormones,1,0,0,1,0,2
human amniotic fluid,0,0,0,2,0,2
hyperimmune immunoglobulin to sars-cov-2 (hivig),0,1,0,1,0,2
î²-hydroxy î²-methyl butyrate (hmb) enriched amino acid,0,0,0,2,0,2
ibrutinib,0,1,0,1,0,2
ibuprofen,0,0,0,2,0,2
id nowâ„¢ covid-19 screening test,2,0,0,0,0,2
igm antibodytest,0,1,0,1,0,2
igm/igg rapid test,0,1,0,1,0,2
iloprost,0,1,0,1,0,2
imatinib,1,0,0,1,0,2
imu-838,0,1,0,1,0,2
inactivated covid-19 vaccine,0,0,0,2,0,2
inactivated sars-cov-2 vaccine (vero cellï¼‰,2,0,0,0,0,2
inactive sars-cov-2 vaccine (vero cell),1,0,0,1,0,2
interferon-ãÿ-1a,0,0,0,0,2,2
interferon-î² 1a,0,0,2,0,0,2
interferon î²-1b,0,0,0,2,0,2
intramuscular vaccine,2,0,0,0,0,2
iota-carrageenan,0,1,0,1,0,2
kb109,0,2,0,0,0,2
kb109 / self supportive care (ssc),0,2,0,0,0,2
kg),0,0,0,2,0,2
l-citrulline,0,1,0,1,0,2
lanadelumab,0,2,0,0,0,2
ledipasvir,0,2,0,0,0,2
life2000â® ventilator,0,0,0,2,0,2
lucira covid-19 all-in-one test kit,0,2,0,0,0,2
lung ultrasound,0,0,0,2,0,2
mad0004j08,1,0,0,1,0,2
"magpro x100 stimulator, b70 fluid-cooled coil",1,0,0,1,0,2
marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),0,0,0,2,0,2
mask,0,2,0,0,0,2
mechanical ventilation,1,0,0,1,0,2
meditation (1 x 20-minute guided audio training),0,0,0,2,0,2
medium dosage inactivated sars-cov-2 vaccine,2,0,0,0,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-,0,0,1,1,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,0,0,1,1,0,2
mefloquine,0,2,0,0,0,2
menacwy,2,0,0,0,0,2
meplazumab,0,1,0,1,0,2
metanebâ® system,0,0,0,2,0,2
microbiome immunity formula,0,0,0,2,0,2
"moderna covid-19 vaccine, mrna-1273 (100 î¼g)",2,0,0,0,0,2
moderna mrna-1273 covid-19 vaccine,0,0,0,2,0,2
mrna-1273.211,1,0,0,1,0,2
mrna-1273.351,2,0,0,0,0,2
musä±c therapy,0,0,0,2,0,2
mvc-cov1901(saline),1,0,0,1,0,2
n-etsd vaccine,1,0,0,1,0,2
nasafytolâ®,0,0,0,2,0,2
nasopharyngeal swabs,1,0,0,1,0,2
ndv-hxp-s 10î¼g (stage a),0,0,0,2,0,2
ndv-hxp-s 1î¼g (stage a),0,0,0,2,0,2
ndv-hxp-s 3î¼g (stage a),0,0,0,2,0,2
neuromuscular electrical stimulation,0,0,0,2,0,2
nicotinamide,0,1,0,1,0,2
nicotinamide riboside,0,0,0,2,0,2
nigella sativa oil,0,1,0,1,0,2
nintedanib,0,0,0,2,0,2
nioâ® (intraosseous access),0,2,0,0,0,2
nitric oxide delivered via lungfitâ„¢ system,0,0,0,2,0,2
normal saline (0.9% sodium chloride solution)- stage 2,2,0,0,0,0,2
normal saline (0.9% sodium chloride solution) - stage 1,2,0,0,0,0,2
nowdx covid-19 test,0,1,0,1,0,2
nusepinâ® 0.1 mg,0,0,0,2,0,2
nusepinâ® 0.2 mg,0,0,0,2,0,2
nutrition,0,0,0,2,0,2
octagam,0,2,0,0,0,2
ofatumumab,0,0,0,2,0,2
omega-3,0,0,0,2,0,2
omega3-fatty acid,0,0,1,1,0,2
omegavenâ®,0,0,0,2,0,2
online support group,1,1,0,0,0,2
opaganib,0,2,0,0,0,2
ophthalmologic exam,0,2,0,0,0,2
oral,0,1,0,1,0,2
oral polio vaccine,1,0,1,0,0,2
oximenâ® 3%,0,2,0,0,0,2
patient navigation (pn),2,0,0,0,0,2
pegylated interferon-î±2b,2,0,0,0,0,2
pentarlandirâ„¢ uppta,0,0,0,2,0,2
pf-06650833,0,0,0,2,0,2
pf-07304814,0,1,0,1,0,2
pfizer-biontech covid-19 vaccine bnt162b2 (30 âµg)( comirnatyâ®),2,0,0,0,0,2
photodynamic therapy,1,1,0,0,0,2
physiotherapy,0,1,0,1,0,2
placebo injection,0,0,0,2,0,2
plitidepsin,0,1,0,1,0,2
plx-pad,2,0,0,0,0,2
povidone-iodine,0,0,0,2,0,2
prayer,0,0,0,2,0,2
preventive information,2,0,0,0,0,2
probiotics,0,2,0,0,0,2
prothioneâ„¢ (6g),2,0,0,0,0,2
protransâ®,0,0,0,2,0,2
psychoeducational intervention,0,0,0,2,0,2
psychological,1,0,0,1,0,2
pul-042,0,2,0,0,0,2
pyronaridine-artesunate,0,2,0,0,0,2
qazcovid-inâ®-vaccine against covid-19,0,2,0,0,0,2
qazcovid-inâ® - covid-19 inactivated vaccine,0,2,0,0,0,2
quality-of-life assessment,0,0,0,2,0,2
rd-x19,0,1,0,1,0,2
recombinant human interferon î±2b spray,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cell) group,0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cell) low-dose group,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cells) high-dose group,2,0,0,0,0,2
reparixin,0,0,0,1,1,2
"resp301, a nitric oxide generating solution",0,0,0,2,0,2
rhea health toneâ®,2,0,0,0,0,2
rosuvastatin,0,1,0,1,0,2
rtb101,1,0,0,0,1,2
ruconest,0,0,0,2,0,2
rutiâ® vaccine,0,0,0,2,0,2
saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,0,2,0,0,0,2
sars-cov-2 recombinant spike protein,1,0,0,1,0,2
sars-cov-2 recombinant spike protein / advax-sm adjuvant,1,0,0,1,0,2
sars-cov-2 rs/matrix-m1 adjuvant,1,0,0,1,0,2
sars-cov-2 virus,1,0,0,1,0,2
scb-2019,1,0,0,1,0,2
scta01,0,1,0,1,0,2
self supportive care (ssc),0,2,0,0,0,2
self supportive care (ssc) alone,0,2,0,0,0,2
self test,0,0,0,2,0,2
selinexor,0,1,0,1,0,2
serum test,0,1,0,1,0,2
silmitasertib,1,0,0,1,0,2
siltuximab,1,0,0,1,0,2
silymarin,0,0,0,2,0,2
simple cognitive task intervention,0,1,0,1,0,2
sodium bicarbonate,2,0,0,0,0,2
sofosbuvir/daclatasvir,0,1,0,1,0,2
sofosbuvir/ledipasvir,0,2,0,0,0,2
standard covid-19 care,0,2,0,0,0,2
standard of care/placebo,0,1,0,1,0,2
stool collection,0,1,0,1,0,2
tacrolimus,0,0,0,2,0,2
take home saliva kits,2,0,0,0,0,2
targeted wellness formula câ„¢ sublingual drops - 1200mg - 30 ml (formula c),0,0,0,2,0,2
td-0903,0,2,0,0,0,2
tele-yoga,0,2,0,0,0,2
teleorientation,0,0,0,2,0,2
"telerehabilitation ä°ntervention, motor learning",0,0,0,2,0,2
tenofovir disoproxil,0,2,0,0,0,2
test,0,0,0,2,0,2
text-messaging (tm),2,0,0,0,0,2
the binaxnowâ„¢ antibody tests measure igg antibodies against sars-cov-2.,0,0,0,2,0,2
"three doses of placebo at the schedule of day 0, 14, 28ï¼ˆhigh-dose groupï¼‰",2,0,0,0,0,2
thromboprophylaxis,0,0,0,2,0,2
thymalfasin,0,0,0,2,0,2
tinzaparin,0,0,0,2,0,2
tricorâ® 145mg tablets,0,0,0,2,0,2
trv027,0,1,0,1,0,2
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,1,0,0,2
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,1,0,0,2
"two doses of placebo at the schedule of day 0, 28ï¼ˆhigh-dose groupï¼‰",2,0,0,0,0,2
"two doses of placebo at the schedule of day 0, 28ï¼ˆmiddle-dose groupï¼‰",2,0,0,0,0,2
txa127,0,1,0,1,0,2
ty027,0,1,0,1,0,2
uvc irradiation,0,2,0,0,0,2
veru-111,1,0,0,1,0,2
vitis xtra forteâ©,0,2,0,0,0,2
viusid/asbrip,1,1,0,0,0,2
volatile organic compounds analysis,0,1,0,1,0,2
writing,0,2,0,0,0,2
xav-19,1,0,0,1,0,2
xc221,0,1,0,1,0,2
yoga,0,0,0,2,0,2
zilucoplanâ®,0,2,0,0,0,2
zinc acetate,1,0,0,1,0,2
zyesamiâ„¢ (aviptadil acetate),0,0,0,2,0,2
- tocilizumab,0,1,0,0,0,1
-cd25,0,0,0,1,0,1
-interferon nebulization,0,1,0,0,0,1
"""sham""-block with placebo (isotone nacl)",0,0,0,1,0,1
),0,0,1,0,0,1
"0, 112 day schedule",0,0,0,1,0,1
"0, 28 day schedule",0,0,0,1,0,1
0.07% cetylpyridinium chloride (cpc) in mouthwash,0,1,0,0,0,1
0.075% cetylpyridinium chloride,0,0,0,1,0,1
0.075% cetylpyridinium chloride (cpc),0,0,0,1,0,1
0.1% sodium hypochlorite,0,0,0,1,0,1
0.12% chg oral rinse,0,0,0,1,0,1
0.12% chlorhexidine gluconate,0,0,0,1,0,1
0.12% chlorhexidine gluconate mouth rinse,0,0,0,1,0,1
0.4ml inj syringe 0.4ml,0,0,0,1,0,1
0.5% povidone iodine,0,0,0,1,0,1
0.5% w,0,0,0,1,0,1
0.5% w/v povidone-iodide,0,0,0,1,0,1
0.5ml,1,0,0,0,0,1
0.6% pvp-i oral,0,0,0,1,0,1
0.6% pvp-i oral/nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,0,0,0,1,0,1
0.6% pvp-i oral/nasal spray to healthy volunteer,0,0,0,1,0,1
0.6% pvp-i oral/nasal spray to moderately ill covid-19 positive patient,0,0,0,1,0,1
0.67ml inj syringe,0,0,0,0,1,1
0.9% (w,1,0,0,0,0,1
0.9% (w/v) saline,1,0,0,0,0,1
0.9% normal saline,0,0,0,1,0,1
0.9% sodium chloride,0,0,0,1,0,1
1 minute sit to stand test,0,1,0,0,0,1
1% hydrogen peroxide,0,0,0,1,0,1
1% povidone iodine (pvp-i),0,0,0,1,0,1
1% pvp- mouthwash,0,0,0,1,0,1
1.5% hydrogen peroxide (h2o2),0,0,0,1,0,1
1.5% w,0,0,0,1,0,1
1.5% w/v hydrogen peroxide,0,0,0,1,0,1
10 to 14 days later,0,0,0,1,0,1
100 mg/ml virazole,0,1,0,0,0,1
"12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",0,1,0,0,0,1
1200 mg),1,0,0,0,0,1
14-day schedule,0,0,0,1,0,1
15mg,0,0,0,1,0,1
16-hour pp,0,0,0,1,0,1
1600 mg),1,0,0,0,0,1
2-way sms delivery of information,0,0,0,1,0,1
2 doses of vaccine,0,0,0,1,0,1
2.2x10^10vp (qpcr) boost,1,0,0,0,0,1
23-valent pneumococcal polysaccharide vaccine,0,0,0,1,0,1
24 hour holter ecg,0,0,0,1,0,1
24h transdermal patch - 24 hour,0,0,0,1,0,1
25 âµg spfn_1b-06-pl,1,0,0,0,0,1
25 âµg spfn_1b-06-pl / alfq (qs21 adjuvant),1,0,0,0,0,1
27% ethanol,0,0,0,1,0,1
27% ethanol/essential oils,0,0,0,1,0,1
28),1,0,0,0,0,1
2nd dose),0,1,0,0,0,1
"3-doses schedule 1 of covid-19 vaccine (vero cell), inactivated",0,0,0,1,0,1
"3-doses schedule 2 of covid-19 vaccine (vero cell), inactivated",0,0,0,1,0,1
"3-doses schedule 3 of covid-19 vaccine (vero cell), inactivated",0,0,0,1,0,1
3 consecutive lots (group c1a),0,0,0,1,0,1
3 consecutive lots (group c2a),0,0,0,1,0,1
3),0,0,0,0,1,1
4-free app,0,1,0,0,0,1
4-free app / phn intervention,0,1,0,0,0,1
400 mg,0,0,0,1,0,1
4plants,0,0,1,0,0,1
4plants/azythromycin,0,0,1,0,0,1
5-ala-phosphate,0,0,0,1,0,1
5-ala-phosphate / sfc (5-ala / sfc),0,0,0,1,0,1
5-week prevention program,1,0,0,0,0,1
5 times sit to stand test,0,1,0,0,0,1
5% glucose,1,0,0,0,0,1
50 âµg spfn_1b-06-pl,1,0,0,0,0,1
50 âµg spfn_1b-06-pl / alfq (qs21 adjuvant),1,0,0,0,0,1
50 mg,0,1,0,0,0,1
50 mg/ml virazole,0,1,0,0,0,1
6-min-walk fpp2,0,0,0,1,0,1
6-min-walk surgical mask,0,0,0,1,0,1
6-min-walk without mask,0,0,0,1,0,1
6 minute walk test,0,1,0,0,0,1
6 minutes walk test,1,0,0,0,0,1
6 months later,0,1,0,0,0,1
6 point likert scale,0,1,0,0,0,1
600mg) oral suspension,0,1,0,0,0,1
a $10 survey incentive,1,0,0,0,0,1
a $20 survey incentive,1,0,0,0,0,1
a 940-nm diode laser,0,0,0,1,0,1
a faithful response to covid-19,0,0,0,1,0,1
"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",0,0,0,1,0,1
a short video intervention,0,0,0,1,0,1
"a single ""booster"" dose of the moderna mrna covid-19 vaccine",0,0,0,1,0,1
a vignette intervention,0,0,0,1,0,1
aapc,0,0,0,1,0,1
aaz covid-19 rapid test,0,1,0,0,0,1
abbc1 immunoessential,0,0,0,1,0,1
abbv-2b04,0,1,0,0,0,1
abbv-47d11,0,1,0,0,0,1
abivertinib,1,0,0,0,0,1
abncov2 vaccine,0,0,0,1,0,1
abx464,0,0,0,0,1,1
accuchek inform ii platform,0,1,0,0,0,1
"ace inhibitor, angiotensin receptor blocker",0,1,0,0,0,1
acknowledgement racial injustice ama,0,1,0,0,0,1
"acp educator led, video assisted discussion",0,0,0,1,0,1
act,0,0,0,1,0,1
actigraphy,0,0,0,1,0,1
action (tara),0,1,0,0,0,1
activase,1,0,0,0,0,1
active comparator,0,0,0,1,0,1
active control:healthy living,0,1,0,0,0,1
active vaccine control (group b1a),0,0,0,1,0,1
active vaccine control (group b1b),0,0,0,1,0,1
active vaccine control (group b1c),0,0,0,1,0,1
active vaccine control (group b1d),0,0,0,1,0,1
active vaccine control (group c2a),0,0,0,1,0,1
active vaccine control (group c2b),0,0,0,1,0,1
active vaccine control (group c2c),0,0,0,1,0,1
active vaccine control simple dose (group b1d),0,0,0,1,0,1
active vaccine control simple dose (group c2d),0,0,0,1,0,1
active vaccine control simple dose (group c2d) - 60 years old,0,0,0,1,0,1
active vaccine control simple dose (group c2d) - 60 years old/more,0,0,0,1,0,1
activity list,0,1,0,0,0,1
acupuncture,0,1,0,0,0,1
acupuncture/standard care,0,1,0,0,0,1
ad5-ncov,1,0,0,0,0,1
adapt-232 oral solution,0,0,0,1,0,1
adcld-cov19,1,0,0,0,0,1
adcld-cov19-1,0,0,0,1,0,1
adcovid,1,0,0,0,0,1
adenovirus type-5 vectored covid-19 vaccine,1,0,0,0,0,1
adimrsc-2f,0,0,0,1,0,1
adm03820,0,0,0,1,0,1
administration of equine immunoglobulin anti sars-cov-2,0,1,0,0,0,1
adsorbed sars-cov-2 (inactivated) vaccine,1,0,0,0,0,1
adx-629,0,0,0,1,0,1
aerobic exercise therapy,0,0,0,1,0,1
aerobic exercises,0,0,1,0,0,1
aerobic training,0,0,0,1,0,1
aerosolized dnase,0,0,0,1,0,1
african american sender acknowledgement,0,1,0,0,0,1
african american sender in informational videos.,0,1,0,0,0,1
after-each-case room disinfection,0,1,0,0,0,1
after covid-19 vaccination,1,0,0,0,0,1
ag0301-covid19,0,1,0,0,0,1
ag0302-covid19,1,0,0,0,0,1
ag0302-covid19 for intradermal injection,0,0,0,1,0,1
ag0302-covid19 for intramuscular injection,0,0,0,1,0,1
agent-797,0,0,0,1,0,1
ai algorithm,0,0,0,1,0,1
airflo2,0,0,0,1,0,1
ak119,0,0,0,1,0,1
akl-t01,0,0,0,1,0,1
aks-452,0,0,0,1,0,1
alanine,0,0,0,1,0,1
albumine,0,1,0,0,0,1
alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,0,0,0,1,0,1
aldesleukin,0,0,0,1,0,1
alfq (qs21 adjuvant),1,0,0,0,0,1
allogeneic,1,0,0,0,0,1
allogeneic human menstrual blood stem cells secretome,0,1,0,0,0,1
allogeneic mesenchymal stem cell,0,1,0,0,0,1
allogeneic wharton's jelly-mscs (wj-msc),0,0,0,1,0,1
almitrine,0,0,0,1,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/5% glucose",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/high-dose vitamin c treatment",1,0,0,0,0,1
alpha one antitrypsin,0,0,0,1,0,1
alpha variant,0,0,0,1,0,1
also no soap (pure control),1,0,0,0,0,1
alteplase,0,0,0,1,0,1
altruism video,0,0,0,1,0,1
alum adjuvant,1,0,0,0,0,1
aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
alvelestat,1,0,0,0,0,1
alveolar,0,0,0,1,0,1
ama acknowledgement drug pricing,0,1,0,0,0,1
amantadine,0,0,0,1,0,1
amantadine hydrochloride,0,0,0,1,0,1
ambulation,0,0,0,1,0,1
amiodarone,0,1,0,0,0,1
amlodipine,0,0,0,1,0,1
amor 18 powder,0,0,0,1,0,1
amor 18 powder/inhalation,0,0,0,1,0,1
amoxicillin,0,0,0,1,0,1
an69-oxiris,0,0,0,1,0,1
an69-standard,0,0,0,1,0,1
anakinra/osoc,0,0,0,0,1,1
anakinra/ruxolitinib,0,0,0,0,1,1
andrographis paniculata,0,0,0,1,0,1
ang-3777,1,0,0,0,0,1
anger message,0,1,0,0,0,1
angiography scanner,0,0,0,1,0,1
angiotensin,0,0,0,1,0,1
angiotensin-(1-7),0,0,0,1,0,1
angiotensin ii receptor blockers,0,0,0,1,0,1
angiotensin peptide (1-7) derived plasma,0,0,0,1,0,1
anise,0,0,0,1,0,1
anluohuaxian,0,0,0,1,0,1
anti-cd14,0,0,0,1,0,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,0,0,0,1,0,1
anti-sars-cov-2,0,0,0,1,0,1
anti-sars-cov-2 igt seropositivity,0,1,0,0,0,1
anti-sars-cov-2 igy,0,1,0,0,0,1
anti-sars-cov-2 mab,0,0,0,1,0,1
anti covid 19 intravenous immunoglobulin (c-ivig),0,0,0,1,0,1
anti sars-cov-2 equine hyperimmune serum,0,0,0,1,0,1
anti sars-cov 2 convalescent plasma in critical covid-19 patients,0,0,0,0,1,1
anti sars-cov 2 convalescent plasma in severe covid-19 patients,0,0,0,0,1,1
antibiotics,0,0,0,1,0,1
antibody test,0,1,0,0,0,1
antibody testing for sars-cov-2 igg,0,0,0,1,0,1
anticoagulants according to different protocols.,0,1,0,0,0,1
anticoagulation agents (edoxaban and,0,0,0,1,0,1
anticoagulation agents (edoxaban and/or high dose lmwh),0,0,0,1,0,1
anticov-220,1,0,0,0,0,1
antigen,0,0,0,1,0,1
antihypertensives,0,0,0,1,0,1
antimicrobial stewardship prospective audit,0,0,0,1,0,1
antimicrobial stewardship prospective audit/feedback,0,0,0,1,0,1
antioxidants,0,0,0,1,0,1
antithrombin,0,1,0,0,0,1
antithrombin / best available treatment,0,1,0,0,0,1
antithrombin iii,0,0,0,1,0,1
antroquinonol,0,0,0,1,0,1
anxiety,0,1,0,0,0,1
anxiety reduction training,1,0,0,0,0,1
ap-23,0,0,0,1,0,1
apilimod dimesylate,0,0,0,1,0,1
apixaban 5mg,1,0,0,0,0,1
apl-9,0,1,0,0,0,1
application of cdss to provide nutritional care in breast cancer patients from home,0,1,0,0,0,1
apps,0,1,0,0,0,1
apremilast,0,1,0,0,0,1
apremilast placebo,0,1,0,0,0,1
aprepitant injectable emulsion,0,0,0,1,0,1
aprotinin,1,0,0,0,0,1
aptamex,0,0,0,1,0,1
arbidol hydrochloride/interferon atomization,0,0,0,1,0,1
arbox,0,0,0,0,1,1
arct-021,0,0,0,1,0,1
arct-021 dose 1,0,1,0,0,0,1
arct-021 dose 2,0,1,0,0,0,1
arct-021 dose 3,0,1,0,0,0,1
arct-021 dose 4,0,1,0,0,0,1
arct-021 dose regimen 1,0,1,0,0,0,1
arct-021 dose regimen 2,0,1,0,0,0,1
arct-021 single dose priming,1,0,0,0,0,1
arct-021 two higher dose priming,1,0,0,0,0,1
arct-021 two lower dose priming,1,0,0,0,0,1
arct-154,0,0,0,1,0,1
arct-165,0,0,0,1,0,1
ardsnet,0,0,0,1,0,1
ardsnet table,0,0,0,1,0,1
argatroban,0,0,0,1,0,1
artemesia annua,0,0,0,1,0,1
artemether-lumefantrine (al),0,0,0,1,0,1
artemic,0,1,0,0,0,1
artemisia annua leaf,0,0,0,0,1,1
artemisinin,0,1,0,0,0,1
asc09,0,0,0,1,0,1
asc09f/oseltamivir,0,0,0,1,0,1
ascorbic acid/zinc gluconate,0,1,0,0,0,1
ashmolean website,0,0,0,1,0,1
asp,0,0,0,1,0,1
aspirin 25mg orally,0,0,0,1,0,1
assembled mask,1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity",1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity/memory b-cell function",1,0,0,0,0,1
assigned strategies: active choice,0,1,0,0,0,1
assigned strategies: enhanced active choice,0,1,0,0,0,1
assigned strategies: opt-in,0,1,0,0,0,1
astrazeneca,0,0,0,1,0,1
astrazeneca/oxford vaccine,0,0,0,1,0,1
astrazenica vaccine,0,0,0,1,0,1
asunercept,0,0,0,1,0,1
asunercept 100mg,0,0,0,1,0,1
asunercept 25mg,0,0,0,1,0,1
asunercept 400mg,0,0,0,1,0,1
asynchronous telerehabilitation programme,0,0,0,1,0,1
at-001,0,1,0,0,0,1
at-100,0,0,0,1,0,1
atazanavir/dexamethasone,0,0,0,1,0,1
ati-450,0,1,0,0,0,1
atorvastatin-ezetimibe,0,0,0,1,0,1
atorvastatin / l-arginine / folic acid / nicorandil / nebivolol,0,0,0,1,0,1
atorvastatin 20 mg oral tablet,0,0,0,1,0,1
atorvastatin 80mg,0,0,0,1,0,1
atovaquone,0,0,0,1,0,1
atovaquone/azithromycin,0,0,0,1,0,1
atr-002,0,0,0,1,0,1
attention bias modification (abm),0,1,0,0,0,1
atyr1923,0,1,0,0,0,1
audio for relaxation techniques,0,0,0,1,0,1
auditory evoked potentials (aep),0,1,0,0,0,1
augmented message,0,0,0,1,0,1
auricular neuromodulation,0,0,0,0,1,1
auricular percutaneous neurostimulation,0,0,0,1,0,1
auricular stimulation,0,0,0,1,0,1
autologous activated platelet-rich plasma,0,0,0,1,0,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),0,1,0,0,0,1
autophagy inhibitor (gns651),1,0,0,0,0,1
auxora,0,1,0,0,0,1
aviptadil acetate,0,0,0,1,0,1
aviptadil placebo,0,0,0,1,0,1
aviptadil/standard care,0,1,0,0,0,1
award,0,0,0,1,0,1
award advice,0,0,0,1,0,1
award/covid-specific advice,0,0,0,1,0,1
azd1656,0,1,0,0,0,1
azd2816,0,0,0,1,0,1
azd7442 (im),0,0,0,1,0,1
azd7442 (iv),0,0,0,1,0,1
azithromycin / ivermectin / ribaroxaban / paracetamol,0,1,0,0,0,1
azithromycin / ribaroxaban / paracetamol,0,1,0,0,0,1
azithromycin pill,0,0,0,1,0,1
azoximer bromide,1,0,0,0,0,1
azvudine,0,0,0,1,0,1
azvudine placebo,0,0,0,1,0,1
"b.1.351)-as03, dosage a",0,0,0,1,0,1
"b.1.351)-as03, dosage b",0,0,0,1,0,1
b: placebo,0,0,0,1,0,1
bacillus subtilis,0,0,0,1,0,1
bactek-r,0,0,0,1,0,1
bactrl-spike,1,0,0,0,0,1
baf312,0,0,0,1,0,1
balanced amino acid,0,0,0,1,0,1
bandebereho fathers',0,0,1,0,0,1
bardoxolone methyl,0,1,0,0,0,1
baricitinib / dexamethasone,0,0,0,1,0,1
baseline,0,0,0,1,0,1
baseline blood sample,0,0,0,1,0,1
baseline disease modifying therapies (dmts),0,0,0,1,0,1
baseline message,0,1,0,0,0,1
baseline/during hospitalization blood samples,0,0,0,1,0,1
basic feedback,0,1,0,0,0,1
bat / calcifediol,0,0,0,1,0,1
bbv152,1,0,0,0,0,1
bbv152a - phase i,1,0,0,0,0,1
bbv152a - phase ii,1,0,0,0,0,1
bbv152b - phase i,1,0,0,0,0,1
bbv152b - phase ii,1,0,0,0,0,1
bbv152c - phase i,1,0,0,0,0,1
bbv154 vaccine,1,0,0,0,0,1
bcg-10 vaccine,0,0,0,1,0,1
bdb-001 injection,0,0,0,1,0,1
beck anxiety inventory,0,1,0,0,0,1
beck depression inventory,0,1,0,0,0,1
behavioral activation ssi,0,1,0,0,0,1
behavioral economics,0,0,0,1,0,1
behavioral intervention,0,0,0,1,0,1
behaviour change technique intervention to improve quality of life,0,0,0,1,0,1
beijing,1,0,0,0,0,1
bemcentinib,1,0,0,0,0,1
bemiparin,0,0,0,1,0,1
bemiparin sodium,0,0,0,1,0,1
bempegaldesleukin,1,0,0,0,0,1
berberine,0,1,0,0,0,1
bereavement virtual support group,0,0,1,0,0,1
best message,0,0,0,1,0,1
best message / augmented message/implementation strategy,0,0,0,1,0,1
best message alone,0,0,0,1,0,1
best standard of care / cardio,0,0,0,1,0,1
best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
betadine (c) mouth rinse with the solution provided,0,0,0,1,0,1
betadineâ© bucal 100 mg,0,1,0,0,0,1
betadineâ© bucal 100 mg/ml,0,1,0,0,0,1
bgb-dxp593,0,1,0,0,0,1
bgb dxp593,0,1,0,0,0,1
bge-175,0,0,0,1,0,1
bi 764198,0,0,0,0,1,1
bi 767551 inhaled,1,0,0,0,0,1
bi 767551 intravenous,1,0,0,0,0,1
bicalutamide 150 mg,0,0,0,0,1,1
bidirectional oxygenation mouthpiece,0,0,0,1,0,1
bio 300 oral suspension,0,0,0,1,0,1
bio101,0,0,0,1,0,1
bioarginina c,0,0,0,1,0,1
biobehavioral tele-rehabilitation sessions,1,0,0,0,0,1
biochemistry blood test,0,0,0,1,0,1
biocollection,0,0,0,1,0,1
biological test,0,0,0,1,0,1
biological/vaccine: bnt162b2 10mcg,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1,0,0,0,0,1
biological: mrna-1273,1,0,0,0,0,1
biontech),0,0,0,1,0,1
biosensor,0,0,0,1,0,1
biospecimen collection,0,0,0,1,0,1
biovitals,0,0,0,1,0,1
biozek covid-19 antigen rapid test,0,0,0,1,0,1
biozek covid-19 antigen rapid test (saliva),0,0,0,1,0,1
bivalirudin,0,0,0,1,0,1
bld-2660,1,0,0,0,0,1
blended gaming covid-19 training system (bgcts),0,0,0,1,0,1
blink,0,1,0,0,0,1
blink/masseter inhibitory reflex,0,1,0,0,0,1
blis k12,0,0,0,1,0,1
blood biomarkers,0,0,0,1,0,1
blood count,1,0,0,0,0,1
blood group determination,0,0,0,1,0,1
blood sample analyses,0,0,0,1,0,1
blood sample/data record,0,0,0,1,0,1
blood sample/salivary sample,0,0,0,1,0,1
blood samples for the study of the humoral response to sars-cov-2 variants,0,0,0,1,0,1
blood samples for the study of the humoral response to sars-cov-2 variants/of the cellular response after vaccination against covid-19,0,0,0,1,0,1
blood test for inflammatory markers,0,0,0,1,0,1
blood test to describe the humoral,0,0,0,1,0,1
blood test to describe the humoral/cellular response to vaccination bnt162b2 in the elderly,0,0,0,1,0,1
blood/derivatives,0,1,0,0,0,1
blood/nasal fluid sampling before/after covid-19 vaccination,1,0,0,0,0,1
bms-986253,0,0,0,1,0,1
bms-986413,0,0,0,1,0,1
bms-986414,0,0,0,1,0,1
bms-986414 / bms-986413,0,0,0,1,0,1
bno 1030,0,1,0,0,0,1
bnt162a1,0,0,0,1,0,1
bnt162b2 20mcg,0,0,0,1,0,1
bnt162b2 30mcg,0,0,0,1,0,1
bnt162b2.b.1.351,0,1,0,0,0,1
bnt162b2sa,0,0,0,1,0,1
bnt162b3,1,0,0,0,0,1
bnt162c2,0,0,0,1,0,1
body odor samples,0,0,0,1,0,1
body position change,0,0,0,1,0,1
boesenbergia,0,0,0,1,0,1
boost,1,0,0,0,0,1
botulinum neurotoxin,0,1,0,0,0,1
bovine lactoferrin,0,0,0,1,0,1
bovine plasma-derived immunoglobulin concentrate,0,0,0,1,0,1
brain mri,0,0,0,1,0,1
brain parenchyma biopsies,0,0,0,1,0,1
brazilian green propolis extract (epp-af),0,1,0,0,0,1
breath biopsy,0,1,0,0,0,1
breath biopsy analysis,0,0,0,1,0,1
breath test,0,1,0,0,0,1
breath test/cheek swab,0,1,0,0,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",0,0,0,1,0,1
breathing exercises,0,1,0,0,0,1
brensocatib,0,1,0,0,0,1
brexanolone,0,0,0,0,1,1
bridge therapy,0,0,0,1,0,1
brief counseling,0,0,0,1,0,1
brief digital imagery-competing task intervention,0,0,0,1,0,1
brief informational infographic,0,1,0,0,0,1
brief interpersonal telepsychotherapy,0,0,1,0,0,1
brief mindfulness based intervention,0,1,0,0,0,1
brief skills for safer living,0,0,0,1,0,1
brilacidin,0,1,0,0,0,1
broad-spectrum cbd oil,0,0,0,1,0,1
bromelain,0,0,0,1,0,1
bromhexine oral tablet and/or hydroxychloroquine tablet,0,0,0,1,0,1
btl-tml-covid,0,1,0,0,0,1
bucillamine,0,0,1,0,0,1
buddy,1,0,0,0,0,1
buddy assigned in community,1,0,0,0,0,1
butterfly iq,0,1,0,0,0,1
c-135-ls,1,0,0,0,0,1
c1 inhibitor human,0,1,0,0,0,1
c144-ls,1,0,0,0,0,1
c144-ls/c-135-ls,1,0,0,0,0,1
c19-ig 20%,0,0,0,1,0,1
c21,0,1,0,0,0,1
calcifediol,0,0,0,1,0,1
calisthenic exercises,0,1,0,0,0,1
camostat mesylate,0,0,0,1,0,1
candesartan,0,0,0,1,0,1
"cannabidiol, pharmaceutically produced with < 5 ppm thc",0,0,0,1,0,1
canrenoate potassium,0,0,0,1,0,1
canswab,0,1,0,0,0,1
cap-1002,0,0,0,1,0,1
capillary collection,0,0,0,1,0,1
capillary collection/testing,0,0,0,1,0,1
cardiac echocardiography,0,1,0,0,0,1
cardiac magnetic resonance imaging (cmr),0,0,0,1,0,1
cardiac pet,0,0,0,1,0,1
cardiac pet/mri,0,0,0,1,0,1
cardiac rhythm monitoring,0,1,0,0,0,1
cardio,0,0,0,1,0,1
cardiopulmonary exercise (centre-based),0,0,0,1,0,1
cardiopulmonary exercise (online-based),0,0,0,1,0,1
cardiopulmonary exercise training,0,0,0,1,0,1
cardiorespiratory exercise,0,0,0,1,0,1
care as usual,0,1,0,0,0,1
caring contacts without an introductory phone call (cc),0,0,1,0,0,1
caring contacts/introductory phone call (cc/),0,0,1,0,0,1
carrageenan nasal,0,0,0,1,0,1
carrageenan nasal spray,0,0,0,1,0,1
carrageenan nasal spray/1% pvp- mouthwash/gargle,0,0,0,1,0,1
carrageenan nasal/throat spray,0,0,0,1,0,1
carragelose,0,0,0,1,0,1
carrimycin,0,0,0,1,0,1
cash transfer,1,0,0,0,0,1
casirivimab / imdevimab,0,0,0,1,0,1
castem,0,0,0,1,0,1
cbd isolate,0,0,0,1,0,1
ccp,0,0,0,1,0,1
cd127lo,0,0,0,1,0,1
cd24fc,0,1,0,0,0,1
cefditoren pivoxil 400mg,0,0,0,1,0,1
celecoxib famotidine,0,0,0,1,0,1
cell therapy protocol 1,0,0,0,1,0,1
cell therapy protocol 2,0,0,0,1,0,1
cellular response to vaccination bnt162b2 in the elderly,0,0,0,1,0,1
centricyte 1000,0,0,0,1,0,1
cerc-002,0,1,0,0,0,1
cerebrolysin,0,1,0,0,0,1
"cerebrospinal fluid sampling, meningeal",0,0,0,1,0,1
"cerebrospinal fluid sampling, meningeal/brain parenchyma biopsies",0,0,0,1,0,1
certified cloth face mask,1,0,0,0,0,1
certified cloth face mask/preventive information,1,0,0,0,0,1
chadox1-s [recombinant],0,0,0,1,0,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1,0,0,0,0,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1,0,0,0,0,1
chadox1 ncov-19 single dose,0,0,0,1,0,1
chadox1 ncov-19 single dose / paracetamol,0,0,0,1,0,1
chadox1 ncov-19 two dose,0,0,0,1,0,1
chadox1 ncov-19 two dose / paracetamol,0,0,0,1,0,1
chadv68-s,0,0,0,1,0,1
chadv68-s-tce,0,0,0,1,0,1
chain-referral,0,0,0,1,0,1
chamindwell,0,0,0,1,0,1
"change in knowledge, motivation, skills, resources",0,0,0,1,0,1
chat-based instant messaging support,0,1,0,0,0,1
chat-based support,0,0,0,1,0,1
chatbot on covid-19 vaccine hesitancy,0,0,0,1,0,1
check-list including lung ultrasound,0,0,0,1,0,1
cheek swab,0,1,0,0,0,1
chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
chest physiotherapy post-covid19,0,0,0,1,0,1
chest x-ray,0,0,0,1,0,1
chiropractic care (more than one visit),0,1,0,0,0,1
chiropractic care (one visit),0,1,0,0,0,1
chlorhexidine gluconate (a) mouth rinse with the solution provided,0,0,0,1,0,1
chlorine dioxide,0,0,0,1,0,1
choice of assignment: active choice,0,1,0,0,0,1
choice of assignment: enhanced active choice,0,1,0,0,0,1
choice of assignment: opt-in,0,1,0,0,0,1
cholecalciferol 6 lakh iu,1,0,0,0,0,1
christmas holiday,1,0,0,0,0,1
chx0.12,0,1,0,0,0,1
chx0.12/cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
ciclã©sonide,0,0,0,1,0,1
ciclesonide nasal,0,0,0,0,1,1
cig axial,0,1,0,0,0,1
cig tilted,0,1,0,0,0,1
cimetra-1,0,0,0,1,0,1
cimetra-2,0,0,0,1,0,1
citrox,0,1,0,0,0,1
ck0802,1,0,0,0,0,1
ckd-314,0,0,0,1,0,1
ckd-314 placebo,0,0,0,1,0,1
ckd-314 placebo/soc,0,0,0,1,0,1
ckd-314/soc,0,0,0,1,0,1
clarithromycin,0,1,0,0,0,1
clarithromycin 500mg,0,1,0,0,0,1
clinical decision support system based on non-invasive multimodal monitoring,1,0,0,0,0,1
clinical examination,0,1,0,0,0,1
clinician endorsement,0,1,0,0,0,1
cliniporator,1,0,0,0,0,1
cliniporatorâ®,0,0,0,1,0,1
cliniporatorâ®/epsgun,0,0,0,1,0,1
clofazimine,0,0,0,1,0,1
closed face shield with surgical face mask use,0,1,0,0,0,1
closys ultra sensitive rinse mouthwash,0,0,0,1,0,1
cm4620-ie (injectable emulsion),0,0,0,1,0,1
co-mestring (co-coping),0,1,0,0,0,1
cobicistat,0,0,0,1,0,1
cod liver oil,0,0,0,1,0,1
coenzyme q10,0,0,0,1,0,1
cognitive,0,0,0,1,0,1
cognitive activity,0,1,0,0,0,1
"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",0,0,0,1,0,1
cognitive behavioral brief-telepsychotherapy,0,0,1,0,0,1
cognitive behavioural group therapy for perinatal anxiety,0,0,0,1,0,1
cognitive training,1,0,0,0,0,1
colchcine,1,0,0,0,0,1
colchicine 0.6 mg,0,0,1,0,0,1
colchicine pill,0,1,0,0,0,1
colchicine/herbal phenolic monoterpene fractions,0,1,0,0,0,1
colchicine/symptomatic treatment (paracetamol),0,0,0,1,0,1
colgate total zero,0,0,0,0,1,1
collagen-polyvinylpyrrolidone,0,0,0,1,0,1
"collection of blood, salivary",0,1,0,0,0,1
"collection of blood, salivary/nasopharyngeal samples.",0,1,0,0,0,1
collective intelligence intervention,0,0,0,1,0,1
colloidal silver,0,0,0,1,0,1
combination,0,1,0,0,0,1
"combination of curcumin, quercetin",0,0,0,1,0,1
"combination of curcumin, quercetin/vitamin d",0,0,0,1,0,1
combination product: js016 (anti-sars-cov-2 monoclonal antibody),0,0,0,1,0,1
combined art,0,0,0,1,0,1
combined art/hydroxychloroquine,0,0,0,1,0,1
comirnaty - biontech manufacturing gmbh,0,0,0,1,0,1
"comirnaty (covid-19, mrna vaccine)",1,0,0,0,0,1
commercial covid-19 vaccine,1,0,0,0,0,1
communication type,0,1,0,0,0,1
"community-based, mobile van testing",0,0,1,0,0,1
community-provided moderna mrna-1273 covid-19 vaccine,0,0,0,1,0,1
community-provided mrna-based covid-19 vaccine,0,0,0,1,0,1
community health worker support,0,1,0,0,0,1
community health workers.,1,0,0,0,0,1
community interest message,0,1,0,0,0,1
community mask,0,1,0,0,0,1
community popular opinion leader (pol) based intervention,0,0,0,1,0,1
comparator,0,1,0,0,0,1
comparison group,1,0,0,0,0,1
compass,1,0,0,0,0,1
compassion exercises,0,0,0,1,0,1
compassion focused intervention,0,1,0,0,0,1
complement dosage,0,0,0,1,0,1
computerized cognitive training,1,0,0,0,0,1
concentrate beetroot juice,0,0,0,1,0,1
concentrated air,0,0,0,1,0,1
concentrated oxygen,0,0,0,1,0,1
concentrated rehabilitation for patients with persistent symptoms post covid-19,0,0,0,1,0,1
concert,0,1,0,0,0,1
concurrent treatment of ptsd,0,0,0,1,0,1
concurrent treatment of ptsd/substance use disorders using prolonged exposure (cope),0,0,0,1,0,1
conestat alfa,1,0,0,0,0,1
confirm sars-cov-2 infection,0,0,0,1,0,1
conjunctival swab/nasopharyngeal swab,0,0,0,1,0,1
contain covid anxiety ssi,0,1,0,0,0,1
continuation of acei,0,0,0,1,0,1
continuation of acei/arb,0,0,0,1,0,1
continuation of arb,0,1,0,0,0,1
continuation of ras blocker,0,0,0,0,1,1
continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
continuous blind glucose measurement device (free style pro),0,0,0,1,0,1
continuous glucose monitor (cgm),0,0,0,1,0,1
"continuous glucose monitoring (cgm, dexcom g6)",0,0,1,0,0,1
continuous positive airway pressure,0,0,0,0,1,1
continuous positive airway pressure (cpap) therapy using oxyjet,1,0,0,0,0,1
continuous vital sign monitoring - isansys patient status engine,0,0,0,1,0,1
contrast-enhanced cmr,0,0,0,1,0,1
control blend,0,0,0,1,0,1
control group - waiting list,0,0,0,1,0,1
control group (standard hospital treatment),0,1,0,0,0,1
control intervention,0,0,0,1,0,1
control message,0,1,0,0,0,1
control patients,0,0,0,1,0,1
control swab,0,0,0,1,0,1
control test,0,0,0,1,0,1
control training group,0,1,0,0,0,1
controlled vaccine,0,0,0,1,0,1
controls,0,0,0,1,0,1
convalescent plasma infusion,0,0,0,1,0,1
convalescent plasma treatment,0,0,0,1,0,1
convalescent plasma with antibody against sars-cov-2.,0,0,0,1,0,1
convalescent plasma/standard care,0,0,0,1,0,1
convalscent plasma,0,0,0,1,0,1
convenient scheduling link,1,0,0,0,0,1
conventional,0,1,0,0,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",0,0,0,1,0,1
conventional n95 respirator,0,0,0,1,0,1
conventional therapy first,1,0,0,0,0,1
convp,0,0,0,1,0,1
cor-101,0,0,0,1,0,1
core warming,0,0,0,1,0,1
corn oil (placebo),0,0,0,1,0,1
coronavirus vaccine,0,0,0,1,0,1
corpus cavernosum electromyography,0,1,0,0,0,1
corvax,1,0,0,0,0,1
cosh self-help smoking cessation booklet,0,0,0,1,0,1
cospherunate,0,0,1,0,0,1
cospherunate/azythromycine,0,0,1,0,0,1
cospherunate/phytomedicine/azythromycien,0,0,1,0,0,1
cost-benefit frame,1,0,0,0,0,1
counselling,1,0,0,0,0,1
"couple hopes guided, internet-delivered, self-help intervention",0,0,0,1,0,1
couples' group education,0,0,1,0,0,1
covac-1,0,0,0,1,0,1
covaxin,0,0,0,1,0,1
covend24,0,0,0,1,0,1
covepit (ose13e),0,0,0,1,0,1
covi-drops,0,0,0,1,0,1
covi-vac,1,0,0,0,0,1
covid-19-impact on quality of life questionnaire,0,0,0,1,0,1
covid-19 antibody test,0,1,0,0,0,1
"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",0,0,0,1,0,1
covid-19 barrier box,0,1,0,0,0,1
covid-19 community outreach,0,0,0,1,0,1
covid-19 community outreach/health promotion.,0,0,0,1,0,1
covid-19 convalescent plasma (cp),1,0,0,0,0,1
covid-19 diagnostic test,0,1,0,0,0,1
covid-19 e-package: psychological wellbeing for healthcare workers,0,1,0,0,0,1
covid-19 individual awareness,0,0,0,1,0,1
covid-19 individual awareness/education.,0,0,0,1,0,1
covid-19 individual health education,0,0,0,1,0,1
covid-19 individual health education/linkages to medical/supportive services.,0,0,0,1,0,1
covid-19 informational text,0,0,0,1,0,1
covid-19 mrna vaccine (nucleoside modified),0,0,0,1,0,1
covid-19 related health warning leaflet,0,0,0,1,0,1
covid-19 rt-pcr test,0,0,0,1,0,1
covid-19 sars-cov igg,0,0,0,1,0,1
covid-19 sars-cov igg/igm antibody rapid test,0,0,0,1,0,1
covid-19 standard of care,0,0,0,1,0,1
covid-19 standard therapy,1,0,0,0,0,1
covid-19 swab,0,0,0,1,0,1
covid-19 symptom monitoring system,0,0,0,1,0,1
covid-19 vaccine astrazeneca suspension for injection,0,0,0,1,0,1
covid-19 vaccine education campaign,0,0,0,1,0,1
covid-19 vaccine hipra 10,1,0,0,0,0,1
covid-19 vaccine hipra 20,1,0,0,0,0,1
covid-19 vaccine hipra 40,1,0,0,0,0,1
covid-19 vaccine janssen (ad26.cov2-s),0,0,0,1,0,1
covid-19 vaccine message,1,0,0,0,0,1
covid-19 vaccine moderna dispersion for injection - moderna biotech,0,0,0,1,0,1
covid-evax,0,0,0,1,0,1
covid-globulin,0,0,0,1,0,1
covid-higiv,0,1,0,0,0,1
covid-specific advice,0,0,0,1,0,1
covid 19 self-questionnaire,0,0,0,1,0,1
covid 19 serology,0,0,0,1,0,1
covid watch,1,0,0,0,0,1
covid wheld,0,0,0,1,0,1
covid19 vaccine,0,1,0,0,0,1
covidfree@home,0,0,0,1,0,1
covidir injections,1,0,0,0,0,1
covigenix vax-001,1,0,0,0,0,1
covigenix vax-001 placebo,1,0,0,0,0,1
covishield,0,0,0,1,0,1
covishield 0.25ml,1,0,0,0,0,1
covishield 0.5ml,1,0,0,0,0,1
coviv,0,1,0,0,0,1
coviv only (1st,0,1,0,0,0,1
coviv only (1st/2nd dose),0,1,0,0,0,1
coviv/iiv4; coviv/ppv23,0,1,0,0,0,1
covivac,0,0,0,1,0,1
covsurf drug delivery system,0,0,0,1,0,1
covvr,0,0,0,1,0,1
cpap helmet,0,0,0,1,0,1
cpc,0,0,0,1,0,1
cpc/zn,0,0,0,1,0,1
cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cpi-006,0,1,0,0,0,1
cpi-006 1 mg,0,0,0,0,1,1
cpi-006 1 mg/kg / soc,0,0,0,0,1,1
cpi-006 2 mg,0,0,0,0,1,1
cpi-006 2 mg/kg / soc,0,0,0,0,1,1
credible messenger,0,0,0,1,0,1
crest pro-health multi-protection mouthwash,0,0,0,1,0,1
cretan iama,0,1,0,0,0,1
cri management,0,0,1,0,0,1
crisis intervention therapy,0,0,1,0,0,1
critical dialogue,0,0,0,1,0,1
crizanlizumab,0,1,0,0,0,1
crp-apheresis,0,0,0,1,0,1
cryo lung biopsies,0,0,1,0,0,1
cryopreserved ex vivo expanded polyclonal cd4,0,0,0,1,0,1
cryopreserved ex vivo expanded polyclonal cd4/cd127lo/-cd25/ t regulatory cells,0,0,0,1,0,1
csl760,0,0,0,0,1,1
cst-2: eidd-2801,0,0,0,1,0,1
cst-2: placebo,0,0,0,1,0,1
cst-5: placebo,0,0,0,1,0,1
csvf,0,0,0,1,0,1
ct-p59/placebo,0,0,0,1,0,1
ctus examination,0,0,0,1,0,1
cuff application with inflation,0,0,0,1,0,1
culturally adapted cognitive behavioral intervention (ca-cbi),0,0,0,1,0,1
cumin,0,1,0,0,0,1
cupping,0,0,0,1,0,1
curently used therapy for covid-19 non-critical patients,0,0,0,1,0,1
current care per ucla treating physicians,1,0,0,0,0,1
current ipac-uhn ppe,0,0,0,1,0,1
currently used therapy,0,0,0,1,0,1
cvncov,1,0,0,0,0,1
cvxga1 high dose,0,0,0,1,0,1
cvxga1 low dose,0,0,0,1,0,1
cyp-001,0,0,0,1,0,1
cyproheptadine,0,0,0,1,0,1
cytokines,0,0,0,1,0,1
cytotoxic t lymphocytes,0,0,0,1,0,1
"d-beta-hydroxybutyrate-(r)-1,3 butanediol monoester",0,0,0,1,0,1
d-dimer test,0,0,0,1,0,1
d followed by enoxaparin,0,1,0,0,0,1
d5w inj,0,0,0,1,0,1
daclastavir 60 mg,0,0,0,1,0,1
daclatasvir 200mg,0,0,0,1,0,1
daclatasvir 60 mg,0,0,0,1,0,1
daily coping toolkit,0,0,0,1,0,1
daily monitoring,0,0,0,1,0,1
daily room disinfection,0,1,0,0,0,1
dalcetrapib,0,1,0,0,0,1
dalteparin,0,0,0,1,0,1
danicopan,0,0,0,1,0,1
danoprevir,0,1,0,0,0,1
danoprevir/ritonavir,0,1,0,0,0,1
dapansutrile capsules,0,0,0,1,0,1
dapsone 100 mg,0,0,0,1,0,1
darunavir,0,0,0,1,0,1
darunavir/cobicistat,0,0,0,1,0,1
das181,0,1,0,0,0,1
data collection/rhinopharyngeal swab,0,1,0,0,0,1
data record,0,0,0,1,0,1
day,0,1,0,0,0,1
day 28.,0,1,0,0,0,1
day for 5 days,0,0,0,1,0,1
db-001,0,1,0,0,0,1
ddpcr,0,0,0,1,0,1
decidual stromal cells (dsc),1,0,0,0,0,1
decision science-based design,0,1,0,0,0,1
decision tool for clinicians,0,0,0,1,0,1
decitabine,0,0,0,1,0,1
dect,0,0,1,0,0,1
deep breathing training,0,1,0,0,0,1
deferoxamine,0,0,0,1,0,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
degarelix,0,1,0,0,0,1
deglycyrrhizinated licorice,0,0,0,1,0,1
delns1-ncov-rbd laiv,1,0,0,0,0,1
derivatives.,0,1,0,0,0,1
desidustat,0,1,0,0,0,1
desmond,1,0,0,0,0,1
determination of covid-19 vacciantion efficacy,0,0,0,1,0,1
device),0,0,0,1,0,1
device: butterfly iq,0,0,0,1,0,1
dexamethasone 2 mg,0,1,0,0,0,1
dexamethasone 2 mg/ml,0,1,0,0,0,1
dexamethasone high dose,0,0,0,1,0,1
dexamethasone low dose,0,0,0,1,0,1
dexamethasone/hydroxychloroquine,0,0,0,0,1,1
dexcom,0,0,0,1,0,1
dfv890,0,1,0,0,0,1
diagnostic,0,1,0,0,0,1
diagnostic laboratory biomarker analysis,0,0,0,1,0,1
diagnostic test covid-19,1,0,0,0,0,1
diagnostic test for sars-cov2 for patients,0,0,0,1,0,1
diagnostic test for sars-cov2 for patients/health staff,0,0,0,1,0,1
diagnostic tests for covid-19 infection,0,0,0,1,0,1
dialectical behavioral therapy (dbt) skills,0,1,0,0,0,1
diclofenac sodium 1gm%,0,1,0,0,0,1
diet,0,0,0,0,1,1
diet/sun exposure,0,0,0,0,1,1
dietary supplement,0,0,0,1,0,1
dietary supplement containing resistant starch,0,0,0,1,0,1
dietary supplementation in patients with covid disease admitted to hospital,0,0,0,1,0,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,0,1,0,0,0,1
dig axial,0,1,0,0,0,1
dig tilted,0,1,0,0,0,1
digital brochure,0,0,0,1,0,1
digital cardiac counseling,0,0,0,1,0,1
digital dance for pd,0,1,0,0,0,1
digital health online platform,0,0,0,1,0,1
digital oximeter monitoring,0,0,0,1,0,1
digital problem solving tool,0,1,0,0,0,1
digital social activity video intervention,0,1,0,0,0,1
digivis visual acuity app,0,0,0,1,0,1
dimethyl fumarate,0,0,0,1,0,1
diovan,0,0,0,0,1,1
dipyridamole er 200mg,0,0,0,1,0,1
dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,0,0,0,1,0,1
direct antigen tests for covid-19,0,1,0,0,0,1
discontinuation of acei,0,0,0,1,0,1
discontinuation of acei/arb,0,0,0,1,0,1
discontinuation of arb,0,1,0,0,0,1
discontinuation of ras blocker,0,0,0,0,1,1
discussion board for social support,0,1,0,0,0,1
discussion board for social support /basic feedback,0,1,0,0,0,1
discussion board for social support/personalized feedback,0,1,0,0,0,1
distance learning,0,0,1,0,0,1
distilled water with the same colorant as the experimental product,0,1,0,0,0,1
dociparstat sodium,0,0,0,0,1,1
doctella telehealth monitoring,1,0,0,0,0,1
doppler echo,1,0,0,0,0,1
dornase alfa,0,1,0,0,0,1
dose finding phase (mtd),0,0,0,1,0,1
dose),1,0,0,0,0,1
double-blind nt-i7,0,0,0,1,0,1
doxazosin 2 mg oral tablet,0,0,0,1,0,1
doxycyclin,0,0,0,1,0,1
doxycycline hcl,0,0,0,1,0,1
doxycyline,0,1,0,0,0,1
dressing for external use,1,0,0,0,0,1
dried blood spot,0,1,0,0,0,1
dried blood spot/venous blood collection,0,1,0,0,0,1
driving pressure,0,0,0,1,0,1
drug covid19-0001-usr,0,0,0,1,0,1
drugs,0,1,0,0,0,1
drugs/supportive care,0,1,0,0,0,1
ds-5670a,1,0,0,0,0,1
duact,0,0,0,1,0,1
dupilumab,0,0,0,1,0,1
dur-928,0,0,0,0,1,1
during hospitalization blood samples,0,0,0,1,0,1
dutasteride 0.5 mg,0,1,0,0,0,1
duty frame,1,0,0,0,0,1
dvx201,0,0,0,1,0,1
dwj1248 with remdesivir,0,0,0,1,0,1
early access,0,0,1,0,0,1
early occupational therapy,0,0,0,1,0,1
ecco2r,0,0,0,1,0,1
economic benefit message,0,1,0,0,0,1
economic freedom message,0,1,0,0,0,1
eculizumab,0,0,0,1,0,1
edoxaban tablets,0,0,0,1,0,1
education.,0,0,0,1,0,1
educational moral injury video,0,0,0,1,0,1
educational program (cartoon),0,0,0,1,0,1
educational video,1,0,0,0,0,1
educational vocal health modules,0,0,0,1,0,1
"educational, culturally appropriate covid-19 messages",0,1,0,0,0,1
eeg,0,1,0,0,0,1
eeg based protocol for deep sedation,0,1,0,0,0,1
effects in oxygenation,0,1,0,0,0,1
effects in oxygenation/hypoxic pulmonary vasoconstriction,0,1,0,0,0,1
ehealth for covid-19 prevention,0,0,0,1,0,1
ehealth for covid-19 prevention/support,0,0,0,1,0,1
eit-group,0,0,0,1,0,1
ejaculated semen sample,0,0,0,1,0,1
electric pad for human external pain therapy,0,0,0,1,0,1
electrical impedance tomography,0,0,0,1,0,1
electrical stimulation,0,0,0,1,0,1
electrical stimulation - sham,0,0,0,1,0,1
electronic portable aromatic rehabilitation (epar) diffuser,0,0,0,1,0,1
electronic stethoscope,0,0,0,1,0,1
elispot,0,0,0,1,0,1
elispot test,0,0,0,1,0,1
elmo project at covid-19: proof of concept,0,1,0,0,0,1
elmo project at covid-19: proof of concept/usability,0,1,0,0,0,1
elmo project at covid-19: study in humans,0,1,0,0,0,1
eltrombopag,0,0,0,1,0,1
emapalumab,0,0,0,0,1,1
embarrassment message,0,1,0,0,0,1
emdr,0,0,0,1,0,1
emergency surgical procedures,0,1,0,0,0,1
emotion management,0,0,0,1,0,1
emotion regulation training based on dbt,0,1,0,0,0,1
emotion regulation training via telehealth,0,0,0,1,0,1
emotional freedom technique,0,1,0,0,0,1
emotional freedom techniques (eft),1,0,0,0,0,1
emotional support plan,0,0,0,1,0,1
empagliflozin,0,0,0,1,0,1
emphasis of academic researchers involvement,1,0,0,0,0,1
emphasis of government involvement,1,0,0,0,0,1
emricasan,0,0,0,1,0,1
emtricitabine 200 mg oral tablet,0,0,0,1,0,1
emtricitabine/tenofovir,0,1,0,0,0,1
emtricitabine/tenofovir disoproxil,0,1,0,0,0,1
emtricitabine/tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],0,0,0,1,0,1
enamel care -cetylpyridinium chloride,0,0,0,1,0,1
endoscopy,0,1,0,0,0,1
endothelial protocol,0,0,0,1,0,1
endotracheal intubation,0,0,0,1,0,1
endurance rmt,0,0,0,1,0,1
endurance rmt/nasal breathing,0,0,0,1,0,1
enduring happiness,0,0,1,0,0,1
enduring happiness/continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
enhanced follow through message,0,0,1,0,0,1
enisamium iodide,0,0,0,1,0,1
eno breathe group,0,0,0,1,0,1
enoxaparin/lovenox,0,0,0,1,0,1
enriched survey feedback,1,0,0,0,0,1
ensifentrine,1,0,0,0,0,1
ent exam,0,0,0,1,0,1
enterally,0,0,0,1,0,1
enzalutamide,0,0,0,0,1,1
ep,0,1,0,0,0,1
epa,1,0,0,0,0,1
epi-net intervention,0,0,0,1,0,1
epic risk score display,0,0,0,1,0,1
eproms assessment,0,1,0,0,0,1
epsgun,0,0,0,1,0,1
equinacea arkopharma,0,0,0,1,0,1
equine covid-19 antiserum,0,0,0,1,0,1
ergonomic training,0,1,0,0,0,1
erucov-vac,0,0,0,1,0,1
erucov-vac 3 âµg,0,0,0,1,0,1
erucov-vac 3 âµg/0.5 ml vaccine,0,0,0,1,0,1
erucov-vac 6 âµg,0,0,0,1,0,1
erucov-vac 6 âµg/0.5 ml vaccine,0,0,0,1,0,1
escin,0,0,0,1,0,1
escola john talabot,0,1,0,0,0,1
esophageal catheter,0,0,0,1,0,1
essence oils,0,0,1,0,0,1
essential oil blend,0,0,0,1,0,1
estetrol monohydrate 15 mg,1,0,0,0,0,1
estradiol,0,0,0,1,0,1
estradiol cypionate 5 mg,0,0,0,1,0,1
estradiol cypionate 5 mg/ml,0,0,0,1,0,1
estrogen therapy,0,0,0,1,0,1
etesevimab,0,0,0,1,0,1
ethnic frame,1,0,0,0,0,1
etoposide,1,0,0,0,0,1
eucorvac-19,0,0,0,1,0,1
evolocumab,0,0,0,1,0,1
exercise booklet,0,0,0,1,0,1
exercise program,0,0,0,1,0,1
exercise test ecg,0,0,0,1,0,1
exercise/nutrition,0,0,0,1,0,1
exercises,0,0,0,1,0,1
exg-5003,0,0,0,1,0,1
exhaled breath sampling,0,1,0,0,0,1
exo-cd24,0,0,0,1,0,1
exosomes overexpressing cd24,1,0,0,0,0,1
expanded hemodialysis for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
experimental,0,0,0,1,0,1
experimental: questionnaire without precaution information,0,1,0,0,0,1
expiratory muscle training group,0,0,0,1,0,1
expiratory muscle training placebo group,0,0,0,1,0,1
extra-cvd virtual care,0,0,0,1,0,1
extract psidii guava,0,1,0,0,0,1
eye movement desensitisation,0,0,0,1,0,1
eye movement desensitisation/reprocessing recent traumatic event protocol,0,0,0,1,0,1
f-652,0,0,0,1,0,1
face-mask niv,0,0,0,1,0,1
face-to-face rehabilitation,0,0,0,1,0,1
face mask,0,1,0,0,0,1
face mask awareness,0,1,0,0,0,1
facebook ads on the importance of staying safe during the thanksgiving,1,0,0,0,0,1
facebook ads on the importance of staying safe during the thanksgiving / christmas holiday,1,0,0,0,0,1
facial mask,0,0,0,1,0,1
faeces samples,1,0,0,0,0,1
family nurture intervention (fni),0,0,0,1,0,1
family risk messaging,0,0,1,0,0,1
familychildcare (provisional name of app),0,0,1,0,0,1
farmalarm,0,1,0,0,0,1
fast dissolving film,1,0,0,0,0,1
fatigue severity scale,0,1,0,0,0,1
favipiravir / currently used therapy,0,0,0,1,0,1
favipiravir / hydroxychloroquine,0,1,0,0,0,1
favipiravir/azithromycin,1,0,0,0,0,1
favipiravir/chloroquine,0,0,0,1,0,1
favipiravir/nitazoxanide,0,1,0,0,0,1
favipiravir/tocilizumab,0,0,0,1,0,1
fb2001,0,0,0,1,0,1
fb2001 placebo,0,0,0,1,0,1
fdg-pet,0,0,0,1,0,1
fdg-pet/ct,0,0,0,1,0,1
fecal sample,1,0,0,0,0,1
feedback,0,0,0,1,0,1
fenofibrate,0,0,1,0,0,1
fenofibrate/fenofibric acid,0,0,1,0,0,1
fenofibric acid,0,0,1,0,0,1
ferinject,0,1,0,0,0,1
ffp,0,0,0,1,0,1
ffp2,0,0,0,1,0,1
ffp2 respirator,0,1,0,0,0,1
ffp3 respirator,0,1,0,0,0,1
filiform needles,0,0,0,1,0,1
filmarray pneumonia,0,1,0,0,0,1
filtration test,0,1,0,0,0,1
financial incentives,1,0,0,0,0,1
fingerstick,0,0,0,1,0,1
firazyr,0,0,0,1,0,1
fixed site standard of care testing,0,0,1,0,0,1
flow controlled ventilation (evone-ventilator),0,0,0,1,0,1
fluorescein,0,1,0,0,0,1
fluoxetine,0,0,0,1,0,1
fluoxetine tablets,0,0,0,1,0,1
fluticasone,0,0,0,1,0,1
fluticasone propionate,0,0,0,1,0,1
fluvoxamine maleate 100 mg [luvox],0,0,0,1,0,1
focal mask,0,0,0,1,0,1
focused,0,0,0,1,0,1
focused/targeted message,0,0,0,1,0,1
follow-up visit,0,0,0,1,0,1
fondapariniux,0,0,0,1,0,1
fondaparinux,0,1,0,0,0,1
food diary,0,0,0,1,0,1
formoterol,0,0,0,1,0,1
foy-305,0,1,0,0,0,1
fp-025 100 mg,0,0,0,1,0,1
fp-025 300 mg,0,0,0,1,0,1
freestyle libre 14 day cgm system,0,1,0,0,0,1
fresh start,0,0,1,0,0,1
fsd201,0,0,0,1,0,1
full spectrum cbd oil,0,0,0,1,0,1
furfat,0,0,0,1,0,1
fx06,0,1,0,0,0,1
gam-covid-vac (rad26),1,0,0,0,0,1
gam-covid-vac (rad26) / gam-covid-vac (rad5),1,0,0,0,0,1
gam-covid-vac (rad5),1,0,0,0,0,1
gam-covid-vac lyo,0,1,0,0,0,1
gam-covid-vac m,0,0,0,1,0,1
gamification,0,0,0,0,1,1
gamunex-c,1,0,0,0,0,1
ganovo,0,1,0,0,0,1
ganovo/ritonavir//-interferon nebulization,0,1,0,0,0,1
"garadacimab, factor xiia antagonist monoclonal antibody",0,1,0,0,0,1
gas exchanges at different peep,0,1,0,0,0,1
gastroscopy in transnasal techique,0,0,0,1,0,1
gbp510 (rbd 10î¼g,1,0,0,0,0,1
gbp510 (rbd 10î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 (rbd 25î¼g,1,0,0,0,0,1
gbp510 (rbd 25î¼g/dose)- stage 2,1,0,0,0,0,1
gbp510 (rbd 25î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 10î¼g,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 2,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 25î¼g,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose)- stage 2,1,0,0,0,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 1,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 2,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose)- stage 2,1,0,0,0,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose) - stage 1,1,0,0,0,0,1
gc4419,0,0,0,0,1,1
gc5131,0,1,0,0,0,1
gender concordant,1,0,0,0,0,1
general communication message,0,0,0,1,0,1
general health education,0,0,0,1,0,1
general lifestyle advice to breast cancer patients by phone,0,1,0,0,0,1
general messages,0,1,0,0,0,1
general practitioner tandem,0,1,0,0,0,1
general recommendation,0,0,0,1,0,1
generic best practices,0,0,0,1,0,1
genetic blood collection,1,0,0,0,0,1
giga-2050,0,0,0,1,0,1
gimsilumab,0,1,0,0,0,1
glatiramer acetate,0,0,0,1,0,1
glenzocimab,0,1,0,0,0,1
gls-1027,0,0,0,1,0,1
gls-1200,0,0,0,1,0,1
gls-5310,0,0,0,1,0,1
glutamine,0,0,0,1,0,1
glycophosphopeptical am3,0,0,0,1,0,1
gm-csf,0,1,0,0,0,1
gns561,0,0,0,1,0,1
go2 peep mouthpiece,0,1,0,0,0,1
gossip intervention,1,0,0,0,0,1
grocery store gift cards,0,0,1,0,0,1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,0,1,0,0,0,1
group a (ag0302-covid19),1,0,0,0,0,1
group a (placebo),1,0,0,0,0,1
group a (sample collection),0,0,0,1,0,1
group a: oropharygeal spray,0,1,0,0,0,1
group a: oropharygeal spray/immunostimulant emulsion,0,1,0,0,0,1
group apixaban,0,1,0,0,0,1
group b (ag0302-covid19),1,0,0,0,0,1
group b (placebo),1,0,0,0,0,1
group b (sample collection),0,0,0,1,0,1
group d:placebo oropharyngeal spray,0,1,0,0,0,1
group d:placebo oropharyngeal spray / placebo taken po,0,1,0,0,0,1
group hydroxychloroquine,0,1,0,0,0,1
group hydroxychloroquine/apixaban,0,1,0,0,0,1
growth mindset ssi,0,1,0,0,0,1
gs-441524,0,1,0,0,0,1
gse,0,0,0,1,0,1
gse/xylitol,0,0,0,1,0,1
guduchi ghan vati,0,1,0,0,0,1
guduchi ghanvati,0,1,0,0,0,1
guided online support program,0,0,0,1,0,1
guilt message,0,1,0,0,0,1
gx-03,0,1,0,0,0,1
gx-19,0,0,0,1,0,1
gx-i7 vehicle,0,0,0,1,0,1
habit,0,0,0,1,0,1
had5-s-fusion/n-etsd (suspension for injection),1,0,0,0,0,1
had5-sfusion,1,0,0,0,0,1
had5-sfusion/ n-etsd (oral capsule),1,0,0,0,0,1
hads,0,0,0,1,0,1
handwashing stations at the public places,1,0,0,0,0,1
handwashing stations at the public places/no soap,1,0,0,0,0,1
hbcc project,1,0,0,0,0,1
hbcc project/soap,1,0,0,0,0,1
hcfwo,0,0,0,1,0,1
hd-tdcs 2ma,0,0,0,1,0,1
hd-tdcs 4ma,0,0,0,1,0,1
health enhancement program,1,0,0,0,0,1
health literacy,0,0,0,1,0,1
health promotion.,0,0,0,1,0,1
health staff,0,0,0,1,0,1
health warning leaflet,0,0,0,1,0,1
healthcare providers' communication about the covid-19 vaccine,0,1,0,0,0,1
healthy lifestyle advise,0,0,0,1,0,1
healthy minds program foundations training,0,1,0,0,0,1
heat therapy,0,0,0,1,0,1
helmet niv,0,0,0,1,0,1
helmet non-invasive ventilation,0,0,0,1,0,1
hematology blood test,0,0,0,1,0,1
hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
hemodynamics changes at different peep,0,1,0,0,0,1
heparin - prophylactic dosage,0,0,0,1,0,1
heparin - therapeutic dosage,0,0,0,1,0,1
hepatitis a vaccine,1,0,0,0,0,1
herbal phenolic monoterpene,0,1,0,0,0,1
hesperidin,0,1,0,0,0,1
hfb30132a,1,0,0,0,0,1
high-dose dexamethasone,0,0,0,0,1,1
high-dose placebo (18-59 years),0,0,0,1,0,1
high-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years),0,0,0,1,0,1
high-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant sars-cov-2 vaccine (cho cell),0,0,0,1,0,1
high-dose vitamin c treatment,1,0,0,0,0,1
high-intensity aerobic training with high protein diet,0,1,0,0,0,1
high dose aerosolized ad5-ncov,0,0,0,1,0,1
high dose bcd-250 injection,0,0,0,1,0,1
high dose corticosteroid,0,0,0,1,0,1
high dose of kbp-covid-19,0,0,0,1,0,1
high dose radiation 100 cgy,0,0,0,1,0,1
high flow nasal oxygen (hfno) treatment,1,0,0,0,0,1
high flow nasal therapy,1,0,0,0,0,1
high intensity interval training,0,1,0,0,0,1
high touch multi-pronged behavioral intervention,0,1,0,0,0,1
hiking challenge,0,1,0,0,0,1
hmsc,0,0,0,1,0,1
hmw-ha,0,0,0,1,0,1
home-based exercise training,0,0,1,0,0,1
home-based sars-cov-2 test kit,0,0,0,1,0,1
home-based stretching,0,1,0,0,0,1
home-based stretching/strengthening exercise,0,1,0,0,0,1
home-cov rule implementation,0,1,0,0,0,1
home based exercises,0,1,0,0,0,1
home based exercises with postural,0,1,0,0,0,1
home based exercises with postural/ergonomic training,0,1,0,0,0,1
home care monitoring,0,0,0,0,1,1
home exercise,0,0,0,1,0,1
home pulse oximetry monitoring,0,1,0,0,0,1
home sample collection of concerning mole with physician supervision,0,1,0,0,0,1
"hormone levels (testosterone, fsh, lh, prolactin)",0,0,0,1,0,1
hospital telemedicine management system,0,0,0,1,0,1
hospital: dd-ca,0,0,0,1,0,1
hospital: usual care (uc),0,0,0,1,0,1
"human coach first, then virtual assistant",0,0,0,1,0,1
human cord tissue mesenchymal stromal cells (hct-msc) manufactured by duke university.,0,0,0,1,0,1
human normal immunoglobulin (ivig),0,0,0,1,0,1
human recombinant interleukin 2,1,0,0,0,0,1
hydrocortisone,0,1,0,0,0,1
hydrogen oxygen generator with nebulizer,0,1,0,0,0,1
hydrogen peroxide,0,0,0,1,0,1
hydrogen peroxide (b) mouth rinse with the solution provided,0,0,0,1,0,1
hydroxychloroquine / metabolic cofactor supplementation,0,0,0,1,0,1
hydroxychloroquine / sorbitol,0,0,0,1,0,1
hydroxychloroquine pill / azithromycin pill,0,0,0,1,0,1
hydroxychloroquine tablets,1,0,0,0,0,1
hydroxychloroquine with azithromycin,0,0,0,1,0,1
"hydroxychloroquine, lopinavir",0,0,0,1,0,1
"hydroxychloroquine, lopinavir/ritonavir/azithromycin/placebo (standard therapy)",0,0,0,1,0,1
hydroxychloroquine/azithromycin/ tocilizumab,0,1,0,0,0,1
hydroxychloroquine/clindamycin,0,1,0,0,0,1
hydroxychloroquine/clindamycin/primaquine,0,1,0,0,0,1
hydroxychloroquine/doxycycline,0,1,0,0,0,1
hydroxychloroquine/lopinavir/ritonavir,0,0,0,1,0,1
hydroxychloroquine/placebo,0,0,0,0,1,1
hydroxyvitamin,0,0,0,1,0,1
hyperimmune globulin,0,0,0,1,0,1
hyperpolarized 129xenon gas,0,0,0,1,0,1
hyperpolarized xe129,0,0,0,1,0,1
hypoxia : 14.3,0,1,0,0,0,1
"hypoxia : 14.3/12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",0,1,0,0,0,1
hypoxic pulmonary vasoconstriction,0,1,0,0,0,1
ibudilast,0,0,0,1,0,1
ic14,0,0,0,1,0,1
icatibant injection,0,1,0,0,0,1
icc vaccine,0,0,0,1,0,1
icosapent ethyl,0,0,0,1,0,1
icosapent ethyl (ipe),0,1,0,0,0,1
icu recovery,0,1,0,0,0,1
icu recovery / physical therapy,0,1,0,0,0,1
idoine complex,0,0,0,1,0,1
ifn beta-1a,0,0,0,1,0,1
ifx-1,0,0,0,1,0,1
igg antibody test,0,1,0,0,0,1
igg dosage,1,0,0,0,0,1
igiv,0,0,0,1,0,1
igm,1,0,0,0,0,1
igm antibody rapid test,0,0,0,1,0,1
igm/igg dosage,1,0,0,0,0,1
iibr-100 high-dose (prime-boost),0,0,0,1,0,1
iibr-100 high-dose (prime),0,0,0,1,0,1
iibr-100 low-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium dose (prime),0,0,0,1,0,1
iibr-100 top-dose (prime-boost),0,0,0,1,0,1
"iibr-100, low dose (prime)",0,0,0,1,0,1
iiv4 for the 1st dose,0,1,0,0,0,1
iiv4 for the 1st dose/ppv23 for the 2nd dose,0,1,0,0,0,1
iiv4; coviv,0,1,0,0,0,1
il-12 plasmid,1,0,0,0,0,1
imatinib mesylate intravenous solution,0,0,0,1,0,1
imm-101,1,0,0,0,0,1
immediate vs. delayed provision of antibody test results,0,1,0,0,0,1
immune globulin,0,1,0,0,0,1
immune plasma,0,0,0,1,0,1
immunofree tablets,0,1,0,0,0,1
immunofree tablets/reginmune capsule,0,1,0,0,0,1
immunogenicity after first,0,0,1,0,0,1
immunogenicity after first/second dose,0,0,1,0,0,1
immunostimulant emulsion,0,1,0,0,0,1
implementation strategy,0,0,0,1,0,1
imunor,0,1,0,0,0,1
in-person postoperative visit,0,0,0,1,0,1
inactivated hepatitis a vaccine,0,0,0,1,0,1
inactivated sars cov 2 vaccine (vero cell) wuhan,1,0,0,0,0,1
inactivated sars cov 2 vaccine (vero cell) wuhan/beijing/placebo,1,0,0,0,0,1
inactivated vaccine booster,1,0,0,0,0,1
inb03,0,0,0,1,0,1
increasing willingness,0,0,0,1,0,1
increasing willingness/uptake of covid-19 testing/vaccination,0,0,0,1,0,1
independent control,0,0,0,1,0,1
indian costus,0,0,0,1,0,1
indomethacin,0,0,0,1,0,1
inflammation (i),0,0,0,1,0,1
inflammation (ii),0,0,0,1,0,1
inflammation (iii),0,0,0,1,0,1
inflammatory cytokines,0,0,0,1,0,1
inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
information assigned in community,1,0,0,0,0,1
information on covid-19,0,1,0,0,0,1
informational sheet,0,1,0,0,0,1
inhalation,0,0,0,1,0,1
inhalation of 5% sodium chloride,0,0,0,1,0,1
"inhalation of 8,4% sodium bicarbonate",0,0,0,1,0,1
inhalation of n-acetylcysteine,0,0,0,1,0,1
inhalation of vitamin c,1,0,0,0,0,1
inhaled aviptadil,0,0,0,1,0,1
inhaled low molecular weight heparin,0,1,0,0,0,1
inhaled type i interferon,0,0,0,1,0,1
injectable placebo,0,0,0,1,0,1
injected cardiac mri,0,1,0,0,0,1
injection,0,0,0,1,0,1
injection of secretome-mscs,0,0,0,1,0,1
inm005,0,1,0,0,0,1
innova lateral flow device,0,1,0,0,0,1
ino-4700,0,0,0,1,0,1
inopulse,0,0,0,0,1,1
inspiratory,0,0,0,1,0,1
inspiratory / expiratory muscle training group,0,0,0,1,0,1
inspiratory / expiratory muscle training placebo group,0,0,0,1,0,1
inspiratory muscle traiing,0,0,0,1,0,1
inspiratory muscle trainer,0,0,0,1,0,1
inspiratory muscle training,0,0,0,1,0,1
inspiratory muscle training (imt),0,0,0,1,0,1
inspiratory muscle training group,0,0,0,1,0,1
inspiratory muscle training placebo group,0,0,0,1,0,1
instrumental activities of daily living shaping,0,0,0,1,0,1
insulin,0,1,0,0,0,1
insulin film,1,0,0,0,0,1
insurance navigation,0,0,0,1,0,1
integral communication strategy (eics),0,0,0,1,0,1
interactive,0,0,0,1,0,1
interactive/2-way sms delivery of information,0,0,0,1,0,1
interferon alfa,0,0,0,1,0,1
interferon gamma human recombinant (ifn-g),0,1,0,0,0,1
interferon/glatiramer acetate,0,0,0,1,0,1
interlukein 6,0,1,0,0,0,1
interlukein 6/procalcitonin serum levels,0,1,0,0,0,1
intermediate dose enoxaparin/ unfractionated heparin,0,1,0,0,0,1
intermittent,0,0,0,0,1,1
internal jugular vein cannulation,0,1,0,0,0,1
internet-based cognitive behavioral therapy,1,0,0,0,0,1
internet-based guided self-help based on cbt principles,0,0,0,1,0,1
internet-based self-help,0,1,0,0,0,1
internet-based self-help after 3 weeks,0,1,0,0,0,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,0,0,0,0,1
internet cognitive behavioral therapy,0,0,0,1,0,1
internet cognitive behavioral therapy/chamindwell,0,0,0,1,0,1
intervention 1: according to dgp,0,0,0,1,0,1
"intervention 2: according to cacioppo ""e.a.s.e.""",0,0,0,1,0,1
intervention app,0,1,0,0,0,1
intervention for tecc model,0,0,0,1,0,1
intervention group coronacope,1,0,0,0,0,1
intervention group_rehabilitation program,0,0,0,1,0,1
intervention program,0,0,0,1,0,1
"intervention, tbn",0,0,0,1,0,1
intervention. early,0,0,0,1,0,1
intervention. early/integral communication strategy (eics),0,0,0,1,0,1
interview by psychologists,0,0,0,1,0,1
intramuscular injection,1,0,0,0,0,1
intranasal ivermectin spray,0,0,0,1,0,1
intranasal spray 1%,0,1,0,0,0,1
intraosseous,0,1,0,0,0,1
intravenous,0,1,0,0,0,1
intravenous antibiotics with low dose steroid.,0,1,0,0,0,1
intravenous drug,0,1,0,0,0,1
intravenous normal saline,0,1,0,0,0,1
intravenous saline injection,0,1,0,0,0,1
introductory phone call (cc,0,0,1,0,0,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,0,1,0,0,0,1
investigational product - viracide,0,1,0,0,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 1, single dose, intranasal drops",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 2, single dose, intranasal drops",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal drops",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal spray",0,0,0,1,0,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, two doses, intranasal drops",0,0,0,1,0,1
iodine,0,0,0,1,0,1
irl201104,0,1,0,0,0,1
is (b cell depletion therapy),0,0,0,1,0,1
is (mmf,0,0,0,1,0,1
is (mmf/mpa),0,0,0,1,0,1
is (mtx),0,0,0,1,0,1
isavuconazonium injection [cresemba],0,0,0,1,0,1
isis 721744,1,0,0,0,0,1
isoflurane inhalant product,0,0,0,1,0,1
isoquercetin,0,0,0,1,0,1
itolizumab,0,1,0,0,0,1
itraconazole,0,0,0,1,0,1
iv tocillizumab (tcz),0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg,0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,0,1,0,0,0,1
ivermectin / doxycycline / placebo,0,1,0,0,0,1
ivermectin / iota-carrageenan,0,1,0,0,0,1
ivermectin / placebo,0,1,0,0,0,1
ivermectin 0.4mg,0,0,0,1,0,1
ivermectin 0.4mg/kg/day for 5 days,0,0,0,1,0,1
ivermectin 06 mg oral tablet,0,0,0,1,0,1
ivermectin 3 mg,0,0,0,1,0,1
ivermectin impregnated mask,0,0,0,1,0,1
ivermectin nasal spray,0,0,0,1,0,1
ivermectin pill,0,0,0,1,0,1
ivermectin powder,0,0,0,1,0,1
"ivermectin,ribavirin ,nitazoxanide",0,0,0,1,0,1
"ivermectin,ribavirin ,nitazoxanide/zinc",0,0,0,1,0,1
ivermectin/doxycycline,0,1,0,0,0,1
ivermectin/doxycyline,0,1,0,0,0,1
ivig,0,1,0,0,0,1
ixekizumab,0,0,0,1,0,1
jing-si-herbal-tea,0,0,0,1,0,1
"jinhua qinggan (jhqg) granules, traditional chinese medicine",0,0,0,1,0,1
kamada anti-sars-cov-2,0,1,0,0,0,1
kan jang capsules,0,0,0,1,0,1
kelea water,0,0,0,1,0,1
ketamine,0,0,0,0,1,1
ketogenic diet,0,0,0,1,0,1
ketogenic diet with phytoextracts,0,0,0,1,0,1
kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
kg eb05 iv,0,0,0,1,0,1
kg once daily,0,1,0,0,0,1
kg;100mg,0,0,0,1,0,1
kg;50mg,0,0,0,1,0,1
kidney biopsy,1,0,0,0,0,1
kinesiotherapy protocol,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 4 âµg,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 4 âµg/0.5 ml vaccine,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 6 âµg,0,0,0,1,0,1
koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 6 âµg/0.5 ml vaccine,0,0,0,1,0,1
kovir oral capsule,0,1,0,0,0,1
kundalini yoga,1,0,0,0,0,1
kundalini yoga/anxiety reduction training,1,0,0,0,0,1
l,0,0,0,1,0,1
l-arginine,0,0,0,1,0,1
l. reuteri dsm 17938,0,0,0,1,0,1
l. reuteri dsm 17938 / vitamin d,0,0,0,1,0,1
lab session,0,1,0,0,0,1
lactobacillus,1,0,0,0,0,1
lactobaciltus rhamnosus gg,0,1,0,0,0,1
lactoferrin,0,0,0,1,0,1
"lactoferrin, green tea extract",0,0,0,1,0,1
lambda 180 mcg s.c,0,0,0,1,0,1
lanadelumab placebo,0,1,0,0,0,1
laryngoscope,0,1,0,0,0,1
laryngoscopy,0,1,0,0,0,1
laser acupoint stimulation(laser pen),0,0,0,1,0,1
late dexamethazone,0,0,0,1,0,1
lau-7b,0,1,0,0,0,1
laughter theraphy,1,0,0,0,0,1
lay telephone coaching,0,1,0,0,0,1
leaf-4l6715,0,0,0,1,0,1
leronlimab,0,0,0,1,0,1
let it out (lio)-c,0,0,0,0,1,1
leukapheresis,0,0,0,1,0,1
leukotriene receptor antagonist,0,0,0,1,0,1
levamisole,0,0,0,1,0,1
levamisole / budesonide/formoterol,0,0,0,1,0,1
levilimab,0,1,0,0,0,1
liberase enzyme,0,0,0,1,0,1
licensed covid-19 vaccine,0,0,0,1,0,1
licensed seasonal influenza vaccine,1,0,0,0,0,1
licorice extract,0,0,0,1,0,1
lidocaine,0,0,0,1,0,1
lidocaine 2%,0,0,0,1,0,1
lifestyle (exercise),0,1,0,0,0,1
lifestyle (meditation),0,1,0,0,0,1
lifestyle change promotion program,0,0,0,1,0,1
lift,0,0,0,1,0,1
ligilactobacillus salivarius mp101,0,0,0,1,0,1
lilly bamlanivimab,0,0,0,1,0,1
lilly bamlanivimab / etesevimab,0,0,0,1,0,1
limbix spark,1,0,0,0,0,1
linagliptin,0,1,0,0,0,1
linagliptin 5 mg,0,0,0,0,1,1
linkages to medical,0,0,0,1,0,1
liposomal,0,1,0,0,0,1
liquid alpha1-proteinase inhibitor (human),0,0,0,1,0,1
listerine zero mouthwash product,0,0,0,1,0,1
"liver, lung, heart",1,0,0,0,0,1
"liver, lung, heart/kidney biopsy",1,0,0,0,0,1
longeveron mesenchymal stem cells (lmscs),0,0,0,1,0,1
longitudinally,0,0,0,1,0,1
lopinavir 200 mg,1,0,0,0,0,1
lopinavir 200 mg / ritonavir 50 mg [kaletra],1,0,0,0,0,1
lopinavir/ ritonavir/remdesivir combination,0,0,0,1,0,1
lopinavir/ritonavir / hydoxychloroquine,0,0,0,1,0,1
lopinavir/ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
losartan 50 mg,0,0,0,1,0,1
losartan 50 mg/spironolactone 25 mg pillules oral use,0,0,0,1,0,1
losmapimod,0,0,0,0,1,1
loss protection,0,0,1,0,0,1
lottery incentive,0,0,1,0,0,1
lovenox,0,0,0,1,0,1
low-dose placebo (18-59 years),0,0,0,1,0,1
low-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years),0,0,0,1,0,1
low-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant sars-cov-2 vaccine (cho cell),0,0,0,1,0,1
low-field magnetic resonance imaging,0,0,0,1,0,1
low-field thoracic magnetic stimulation (lf-thms),0,0,1,0,0,1
low-intensity aerobic training,0,1,0,0,0,1
low-molecular-weight heparin,0,0,0,1,0,1
low dose,0,0,0,1,0,1
low dose aerosolized ad5-ncov,0,0,0,1,0,1
low dose bcd-250 injection,0,0,0,1,0,1
low dose low molecular weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin/placebo,0,0,0,1,0,1
low dose of kbp-covid-19,0,0,0,1,0,1
low dose prednisolone,0,0,0,1,0,1
low dose rmt,0,0,0,1,0,1
low dose/high dose bcd-250 injection,0,0,0,1,0,1
low tailored message,1,0,0,0,0,1
low tailored message/covid-19 vaccine message,1,0,0,0,0,1
low/upper respiratory tract sample,0,0,0,1,0,1
lsalt peptide,1,0,0,0,0,1
"ltx-109 gel, 3%",0,0,0,1,0,1
lucinactant,0,0,0,1,0,1
lung impedance,0,0,0,1,0,1
lung low dose radiation,0,0,0,1,0,1
lung mechanics at different peep,0,1,0,0,0,1
lung ultrasonography,0,1,0,0,0,1
lung ultrasound use in patients hospitalized with covid,0,0,0,1,0,1
lus fourteen area,0,1,0,0,0,1
lus twelve area,0,1,0,0,0,1
lv-smenp-dc vaccine,0,0,0,1,0,1
lv-smenp-dc vaccine/antigen-specific ctls,0,0,0,1,0,1
ly3127804,0,0,0,0,1,1
ly3853113,1,0,0,0,0,1
lyt-100,0,0,0,1,0,1
m-m-r ii â® vaccine,1,0,0,0,0,1
m capsules 148 mg,0,1,0,0,0,1
m5049,0,1,0,0,0,1
machine learning,0,0,0,1,0,1
machine learning/ai algorithm,0,0,0,1,0,1
maf capsules 148 mg,0,1,0,0,0,1
magnesium citrate,0,0,0,1,0,1
magnesium citrate/probiotic,0,0,0,1,0,1
magnesium stearate),0,0,0,1,0,1
magnetic resonance spectroscopy (mrs).,0,0,0,1,0,1
magventure magpro system with brainsight neuronavigation device,0,0,0,1,0,1
maintenance,0,0,0,1,0,1
makair,0,0,0,1,0,1
management by a medical student,0,1,0,0,0,1
manremyc,0,0,0,1,0,1
manual acupuncture,0,0,0,1,0,1
maraviroc / currently used therapy,0,0,0,1,0,1
maraviroc experimental group,0,0,0,1,0,1
maraviroc/favipiravir/ct,0,0,0,1,0,1
mas825,0,1,0,0,0,1
masitinib,0,0,0,1,0,1
masked saline placebo,1,0,0,0,0,1
masseter inhibitory reflex,0,1,0,0,0,1
matrix-m adjuvant - phase 2,1,0,0,0,0,1
matrix-m1 adjuvant (crossover vaccination period),1,0,0,0,0,1
matrix-m1 adjuvant (initial vaccination period),1,0,0,0,0,1
matrix m1-adjuvant,1,0,0,0,0,1
maximal effort test,0,0,0,1,0,1
mcgrath videolaryngoscope,0,1,0,0,0,1
mct,0,0,0,1,0,1
me,0,1,0,0,0,1
me/my wishes,0,1,0,0,0,1
media intervention,0,0,0,1,0,1
medical evaluation,1,0,0,0,0,1
medical mask,0,0,0,1,0,1
medical record review - inpatient treatment,0,0,0,1,0,1
medical research council (mrc) dyspnea scale,0,1,0,0,0,1
medication review,1,0,0,0,0,1
meditation app usage,0,1,0,0,0,1
meditation therapy,0,0,0,1,0,1
meditation/anxiety reduction training,1,0,0,0,0,1
medium chain triglyceride oil,0,0,0,1,0,1
medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,0,0,0,1,0,1
medium dose prednisolone,0,0,0,1,0,1
mefloquine as a prophylaxis against sars-cov-2 infection in household contacts of covid 19 confirmed cases,0,0,0,1,0,1
mefloquine/azithromycin/ tocilizumab,0,1,0,0,0,1
mejoracare,0,0,0,1,0,1
melatonin intravenous,0,1,0,0,0,1
melphalan,0,0,0,1,0,1
memory b-cell function,1,0,0,0,0,1
menacwy prime,0,0,0,1,0,1
menacwy prime/saline placebo boost / paracetamol,0,0,0,1,0,1
menacwy single dose,0,0,0,1,0,1
menacwy single dose / paracetamol,0,0,0,1,0,1
menacwy vaccine,1,0,0,0,0,1
mencare,0,0,1,0,0,1
mencare//bandebereho fathers'/couples' group education,0,0,1,0,0,1
mental imagery,0,0,0,1,0,1
mental well-being,0,1,0,0,0,1
"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%,",0,1,0,0,0,1
"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%,/diclofenac sodium 1gm%",0,1,0,0,0,1
merimepodib,0,0,0,0,1,1
mesenchymal stem cells transplantation,0,1,0,0,0,1
mesenchymal stromal cell-based therapy,0,0,0,1,0,1
mesenchymalÂ stem cells/heparin,0,1,0,0,0,1
mesencure,0,0,0,1,0,1
messaging,0,1,0,0,0,1
metabolic cofactor supplementation,0,0,0,1,0,1
metenkefalin,0,1,0,0,0,1
metenkefalin / tridecactide,0,1,0,0,0,1
metformin,0,0,0,1,0,1
metformin glycinate,0,1,0,0,0,1
methotrexate-lde phase 1,0,0,0,1,0,1
methotrexate-lde phase 2,0,0,0,1,0,1
methylene-blue photodisinfection,0,0,0,1,0,1
methylene blue/ vitamin c/n-acetyl cysteine,0,0,0,1,0,1
methylene blue/photodynamic therapy,0,1,0,0,0,1
methylprednisolone group,1,0,0,0,0,1
methylprednisolone injectable product,0,0,0,1,0,1
methylprednisolone injection,0,1,0,0,0,1
methylprednisolone tablet,0,0,0,1,0,1
mf59 adjuvanted sars-cov-2 sclamp vaccine,1,0,0,0,0,1
mfs,0,0,0,1,0,1
mhealth assessments,0,0,0,1,0,1
mhealth platform,0,0,0,1,0,1
microcrystalline cellulose capsule,0,0,0,1,0,1
micronized,0,1,0,0,0,1
"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",0,1,0,0,0,1
mind body syndrome therapy for long covid,0,0,0,1,0,1
mindfullness training,0,1,0,0,0,1
mindfulness-based cognitive therapy,0,0,0,1,0,1
mindfulness-based health promotion,0,0,0,1,0,1
mindfulness-based stress reduction,0,0,0,1,0,1
mindfulness based cognitive therapy for resilience during covid-19,0,0,0,1,0,1
mindfulness based cognitive therapy for resilience during covid-19/chamindwell,0,0,0,1,0,1
mindfulness practice,1,0,0,0,0,1
mindfulness rounds,0,1,0,0,0,1
mindfulness session(s),0,1,0,0,0,1
minimal attention control intervention,0,0,0,0,1,1
miniprobe alveoflex,0,0,0,1,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste",1,0,0,0,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation",1,0,0,0,0,1
ml intravenous solution [actemra]_#1,0,0,0,0,1,1
ml intravenous solution [actemra]_#1 (2 doses),0,0,0,0,1,1
ml oral solution [calcidol],0,1,0,0,0,1
ml prefilled syringe [kineret],0,1,0,0,0,1
mls laser,0,1,0,0,0,1
mobile mental health app - 1,0,1,0,0,0,1
mobile mental health app - 2,0,1,0,0,0,1
mobile mental health app - 3,0,1,0,0,0,1
mobile mental health app - 4,0,1,0,0,0,1
moderate exercise training (age group 1; young adult 17 -30 years),0,0,0,1,0,1
moderate exercise training (age group 2; 31 to 45 years),0,0,0,1,0,1
moderate exercise training (age group 3; above 45 years),0,0,0,1,0,1
moderate intensity aerobic exercises,0,1,0,0,0,1
moderna,1,0,0,0,0,1
moderna mrna-1273,0,0,0,1,0,1
moderna mrna-1273 vaccine,0,0,0,1,0,1
modified bai he gu jin tang,0,0,0,1,0,1
modified ipac-uhn ppe,0,0,0,1,0,1
molecular hydrogen,0,0,0,1,0,1
molgramostim nebuliser solution,0,0,0,1,0,1
molixan,0,0,0,1,0,1
mometasone furoate nasal spray,0,1,0,0,0,1
mon002,0,0,0,1,0,1
monalizumab,1,0,0,0,0,1
monitoring,0,0,0,1,0,1
monitoring of the immune response,0,0,0,1,0,1
monitoring visit,0,0,0,0,1,1
monoclonal antibody,0,0,0,1,0,1
montmorrillonite,0,1,0,0,0,1
more,0,0,0,1,0,1
motivation,0,0,0,1,0,1
motivational interviewing,0,0,0,1,0,1
motivational interviewing/covid-19 symptom monitoring system,0,0,0,1,0,1
motivational messages,0,1,0,0,0,1
mout-to-mouth ventilation,0,1,0,0,0,1
mout-to-mouth ventilation with quantitative analysis,0,1,0,0,0,1
"mouthpiece b1(mouthpiece mpc-st gmdn:62534 generic name: endoscopic bite block, basic, reusable",1,0,0,0,0,1
mouthrinse with bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse with bãªta-cyclodextrin/citrox,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin/citrox,0,1,0,0,0,1
mouthwash,0,1,0,0,0,1
mouthwash/nose rinse with the agnps solution,0,1,0,0,0,1
mouthwashes,0,1,0,0,0,1
mouthwashes/nose rinse in a conventional way,0,1,0,0,0,1
moxibustion,0,0,0,1,0,1
moxibustion/cupping,0,0,0,1,0,1
mp0420,0,0,0,1,0,1
mpa),0,0,0,1,0,1
mqfpd,0,0,0,1,0,1
mr,1,0,0,0,0,1
mr/m-m-r ii â® vaccine,1,0,0,0,0,1
mrg-001,1,0,0,0,0,1
mri,0,0,0,1,0,1
mrna-1273 sars-cov-2 vaccine,0,0,0,1,0,1
mrna-1273 sars-cov-2 vaccine from moderna,1,0,0,0,0,1
mrna-1273 vaccine,1,0,0,0,0,1
mrna-1273 vaccine (moderna),0,0,0,1,0,1
mrna-1273 vaccine (pfizer,0,0,0,1,0,1
mrna-1273 vaccine (pfizer/biontech),0,0,0,1,0,1
mrna-1273.617.2,1,0,0,0,0,1
mrna-1283,1,0,0,0,0,1
mrna covd19 vaccine,0,0,0,1,0,1
mrna covid-19 vaccine,0,0,0,1,0,1
mrna vaccine booster,1,0,0,0,0,1
msc,0,0,0,1,0,1
mstt1041a,0,1,0,0,0,1
mucodentol,0,0,0,1,0,1
multi-omics,0,0,0,1,0,1
multidisciplinary rehabilitation,0,0,0,1,0,1
multipeptide cocktail,1,0,0,0,0,1
multistem,0,0,0,1,0,1
multivitamin with 11mg of zinc,0,1,0,0,0,1
muscle-target oral nutritional supplementation,0,0,0,1,0,1
muscle biopsy,0,1,0,0,0,1
muscle relaxation therapy,0,0,0,1,0,1
museum virtual guided tours,0,1,0,0,0,1
mva-sars-2-s vaccinations (days 0,1,0,0,0,0,1
mva-sars-2-s vaccinations (days 0/28),1,0,0,0,0,1
mva-sars-2-st,0,0,0,1,0,1
mvc-cov1901,1,0,0,0,0,1
mvc-cov1901 (high-dose),1,0,0,0,0,1
mvc-cov1901(mid-dose),1,0,0,0,0,1
mw33 injection,0,0,0,1,0,1
mw33 injection placebo,0,0,0,1,0,1
my wishes,0,1,0,0,0,1
n-803,1,0,0,0,0,1
n-acetyl glucosamine (nag),1,0,0,0,0,1
n-etsd (oral capsule),1,0,0,0,0,1
n-etsd (suspension for injection),1,0,0,0,0,1
n95 respirator,0,0,0,1,0,1
na-831/atazanavir,0,0,0,1,0,1
na-831/dexamethasone,0,0,0,1,0,1
nad,0,0,0,1,0,1
nad/,0,0,0,1,0,1
nangibotide,0,0,0,1,0,1
nanocovax,0,0,0,1,0,1
naproxen,0,0,0,0,1,1
narrow band ultraviolet b-band light,0,0,0,1,0,1
narsoplimab,0,0,0,1,0,1
nasal,0,0,0,1,0,1
nasal breathing,0,0,0,1,0,1
nasal fluid sampling before,1,0,0,0,0,1
nasal lavage,0,0,1,0,0,1
nasal spray by distilled water to control group,0,0,0,1,0,1
nasal spray containing anti-sars-cov-2 antibodies derived from bovine colostrum,0,1,0,0,0,1
nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,0,0,0,1,0,1
nasal spray to healthy volunteer,0,0,0,1,0,1
nasal spray to moderately ill covid-19 positive patient,0,0,0,1,0,1
nasopharyngeal,0,0,0,1,0,1
nasopharyngeal samples.,0,1,0,0,0,1
nasopharyngeal/throat/oropharyngeal swabs analyses by rt-pcr/ddpcr,0,0,0,1,0,1
nasopharynx,0,0,0,0,1,1
nasovax,0,0,0,0,1,1
nature,0,0,1,0,0,1
nature only,0,0,1,0,0,1
nature/mindfulness,0,0,1,0,0,1
navigation services,0,0,0,1,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g/dose),1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g/dose),1,0,0,0,0,1
nbt-nm108,0,0,0,1,0,1
ndv-hxp-s b.1351 vaccine (group b1e),0,0,0,1,0,1
ndv-hxp-s p.1 vaccine (group b1e),0,0,0,1,0,1
ndv-hxp-s p.1 vaccine (group b2a),0,0,0,1,0,1
ndv-hxp-s p.1.351 vaccine (group b2a),0,0,0,1,0,1
ndv-hxp-s parental vaccine (group b1b),0,0,0,1,0,1
ndv-hxp-s parental vaccine (group b1c),0,0,0,1,0,1
ndv-hxp-s parental vaccine in 3 consecutive lots (group b1a),0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group b1d),0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group b1d) - 60 years old,0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group b1d) - 60 years old/more,0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group c2d),0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group c2d) - 60 years old,0,0,0,1,0,1
ndv-hxp-s parental vaccine simple dose (group c2d) - 60 years old/more,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1b),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1c),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1c) - 60 years old,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c1c) - 60 years old/more,0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c2b),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant (group c2c),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant / 3 consecutive lots (group c1a),0,0,0,1,0,1
ndv-hxp-s vaccine based in variant / 3 consecutive lots (group c2a),0,0,0,1,0,1
nebivolol,0,0,0,1,0,1
nebulised heparin,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 1,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 imv,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 niv,0,0,0,1,0,1
nebulised unfractionated heparin (ufh),0,0,0,1,0,1
nebulized administration of zyesamiâ„¢,0,0,0,1,0,1
nebulized administration of zyesamiâ„¢/placebo,0,0,0,1,0,1
nebulized furosemide,0,0,0,1,0,1
nebulized platelet lysate,1,0,0,0,0,1
nebulized saline,0,0,0,1,0,1
nebulized sterile saline,1,0,0,0,0,1
negative control,0,0,0,1,0,1
neonatal resuscitation with ppe for the prevention of sars-cov-2 infection,0,1,0,0,0,1
neonatal resuscitation without ppe for the prevention of sars-cov-2 infection,0,1,0,0,0,1
neuro,0,1,0,0,0,1
neuro -,0,1,0,0,0,1
neuro /,0,1,0,0,0,1
neurocognitive assessment,0,0,0,1,0,1
neurology test,0,0,1,0,0,1
neuromuscular,0,0,0,1,0,1
neutral writing control,0,0,0,0,1,1
new ppe,0,1,0,0,0,1
news,0,0,0,0,1,1
news-2 score,1,0,0,0,0,1
news score,0,0,0,1,0,1
ng test,0,1,0,0,0,1
ngm621,0,0,0,1,0,1
niagen,0,0,0,1,0,1
niclosamide oral tablet,0,0,0,1,0,1
niclosamide suspension,0,0,0,1,0,1
nicorandil,0,0,0,1,0,1
nicotine 7 mg,0,0,0,1,0,1
nicotine 7 mg/ 24h transdermal patch - 24 hour,0,0,0,1,0,1
nicotine patch,0,0,0,1,0,1
nigella,0,0,0,1,0,1
nigella sativa,0,1,0,0,0,1
nigella sativa / black cumin,0,1,0,0,0,1
nigella sativa capsule twice daily,0,0,0,1,0,1
nigella sativa seed,0,0,0,1,0,1
nintedanib 150 mg [ofev],0,0,0,1,0,1
nirs (near-infrared spectroscopy),0,0,0,1,0,1
nitazoxanide/atazanavir/ritonavir,0,0,0,1,0,1
nitazoxanide/ciclã©sonide,0,0,0,1,0,1
nitrate-deplete beetroot juice,0,0,0,1,0,1
"nitric oxide lozenges, 30 mg",0,0,0,1,0,1
nitroglycerin,0,0,0,1,0,1
nk-1r antagonist,0,0,0,1,0,1
no activities of the hbcc project,1,0,0,0,0,1
no activities of the hbcc project/also no soap (pure control),1,0,0,0,0,1
no instruction regarding positioning,0,0,0,1,0,1
no intervention,0,1,0,0,0,1
no message,1,0,0,0,0,1
no messaging,1,0,0,0,0,1
no personal protective equipment (ppe),0,1,0,0,0,1
no racial inequality highlighting,0,1,0,0,0,1
no research related technology based social interactions,0,1,0,0,0,1
no rinsing,0,0,0,1,0,1
no soap,1,0,0,0,0,1
non-contact mce system,0,1,0,0,0,1
non-deceptive placebo,0,1,0,0,0,1
non-mindfulness intervention,0,1,0,0,0,1
non-operative management,0,0,0,0,1,1
non narrow band ultraviolet b-band light,0,0,0,1,0,1
normal saline intranasal,0,0,0,0,1,1
normal saline intranasal/placebo inhaler,0,0,0,0,1,1
normal saline placebo,1,0,0,0,0,1
nose rinse in a conventional way,0,1,0,0,0,1
nose rinse with the agnps solution,0,1,0,0,0,1
not bravery message,0,1,0,0,0,1
novaferon,0,0,0,1,0,1
novottf-100l,0,1,0,0,0,1
nox66,0,1,0,0,0,1
np-120 (ifenprodil),0,1,0,0,0,1
ntr-441,0,0,0,1,0,1
nudge,0,0,0,0,1,1
nurse-community-family partnership intervention,0,0,0,1,0,1
nutrition consult,1,0,0,0,0,1
nutrition consult/protein supplementation,1,0,0,0,0,1
nuvastatic,0,0,0,1,0,1
observation,1,0,0,0,0,1
obvio-19 app,1,0,0,0,0,1
ocat,0,0,0,1,0,1
octaplas,0,0,0,1,0,1
of the cellular response after vaccination against covid-19,0,0,0,1,0,1
offsite pcr testing,0,1,0,0,0,1
ointment,1,0,0,0,0,1
ointment/dressing for external use,1,0,0,0,0,1
"ol-1, high dose",0,0,0,1,0,1
"ol-1, standard dose",0,0,0,1,0,1
old ppe,0,1,0,0,0,1
olfactometry,0,0,0,1,0,1
olokizumab,0,1,0,0,0,1
omega 3 fatty acid,0,0,0,1,0,1
omega 3/nigella sativa oil,0,0,0,1,0,1
omega 3/nigella sativa oil/anise seed capsule,0,0,0,1,0,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,0,0,0,1,0,1
omega 3/nigella sativa oil/indian costus,0,0,0,1,0,1
omega 3/nigella sativa oil/quinine pills,0,0,0,1,0,1
omega dha,1,0,0,0,0,1
omega dha / epa,1,0,0,0,0,1
omeprazole,0,0,0,1,0,1
omni-biotic pro vi 5,0,0,0,1,0,1
omnibiotic aad,0,0,0,1,0,1
on-ice testing while wearing a face mask,0,0,0,1,0,1
on-ice testing while wearing a sham face mask,0,0,0,1,0,1
on-site testing (lumiradx),0,0,0,1,0,1
one covid-19 vaccine candidate (tmv-083,0,1,0,0,0,1
one covid-19 vaccine candidate (tmv-083/v-591) administration - high dose,0,1,0,0,0,1
one dose of bnt162b2 vaccine,1,0,0,0,0,1
one dose quadrivalent influenza vaccine on day 0,0,1,0,0,0,1
one dose quadrivalent influenza vaccine on day 14.,0,1,0,0,0,1
one step test,1,0,0,0,0,1
online bibliotherapy programme,0,1,0,0,0,1
online cognitive behavioral therapy (cbt),0,1,0,0,0,1
online cognitive stimulation therapy,0,0,0,1,0,1
online interactive courses,0,1,0,0,0,1
online intervention grief covid-19,0,0,0,1,0,1
online intervention mental health covid-19,0,0,0,1,0,1
online kkh sports singapore program with usual care,1,0,0,0,0,1
online lifestyle intervention,0,1,0,0,0,1
online questionnaires,0,0,0,1,0,1
online self-help intervention,0,1,0,0,0,1
online social network,0,0,0,1,0,1
online social network/collective intelligence intervention,0,0,0,1,0,1
onsite pcr testing,0,1,0,0,0,1
onsite point-of-care,0,0,0,1,0,1
op-101,1,0,0,0,0,1
open label bss (pepto bismol),0,0,0,1,0,1
operative management,0,0,0,0,1,1
ophtamesone,0,0,0,1,0,1
opn-019,0,0,0,1,0,1
opt-in (call-back),0,1,0,0,0,1
opt-in (in-bound),0,1,0,0,0,1
opt-in recruitment email,0,1,0,0,0,1
opt-out framing,0,1,0,0,0,1
opt-out recruitment email,0,1,0,0,0,1
optical coherence tomography (oct),0,0,0,1,0,1
or high dose lmwh),0,0,0,1,0,1
"or psychotherapy, n=10)",1,0,0,0,0,1
oral-b mouth sore mouthwash,0,0,0,1,0,1
oral-bâ® gum,0,0,0,1,0,1
oral-bâ® gum/enamel care -cetylpyridinium chloride,0,0,0,1,0,1
oral anti-coagulant,0,1,0,0,0,1
"oral antibiotic, antihistamine, anti-inflammatory, multivitamins",0,1,0,0,0,1
oral intervention with cetylpyridinium chloride,0,1,0,0,0,1
oral ivermectin,0,0,0,1,0,1
oral low dose steroid,0,1,0,0,0,1
oral polio vaccine / information,1,0,0,0,0,1
oral/nasal spray by distilled water to control group,0,0,0,1,0,1
orally suspension of cov2-ogen1,0,0,0,1,0,1
organic brown rice,0,0,0,1,0,1
oropharyngeal swabs analyses by rt-pcr,0,0,0,1,0,1
oseltamivir 75mg,0,0,0,1,0,1
osoc,0,0,0,0,1,1
osteopathic manipulative treatment (omt),0,0,0,1,0,1
otilimab,0,1,0,0,0,1
overcoming anxiety in pregnancy,0,0,0,1,0,1
overcoming anxiety in pregnancy/postpartum online self-directed program,0,0,0,1,0,1
oxaloacetate medical food,0,0,0,1,0,1
oxaloacetate medical food/dietary supplement,0,0,0,1,0,1
oxford vaccine,0,0,0,1,0,1
oxygen-ozone,0,0,0,1,0,1
oxygen mask,0,1,0,0,0,1
oxygen therapy/physical therapy,1,0,0,0,0,1
oxyhydrogen,0,0,0,1,0,1
ozanimod,0,0,0,1,0,1
ozone,0,0,0,1,0,1
p2et (caesalpinia spinosa extract),0,0,0,1,0,1
p2y12,0,0,0,1,0,1
pacritinib,1,0,0,0,0,1
palmitoylethanolamide,0,0,0,1,0,1
pamrevlumab,0,0,0,0,1,1
parent,0,1,0,0,0,1
parent positive,1,0,0,0,0,1
parent/peer presence,0,1,0,0,0,1
parentchat for parents of children ages 2-17,0,0,0,1,0,1
parents during induction,0,0,0,1,0,1
part a,0,0,0,1,0,1
part a/b: placebo,0,0,0,1,0,1
part a: upamostat 200 mg,0,0,0,1,0,1
part a: upamostat 400 mg,0,0,0,1,0,1
part b: upamostat 200,0,0,0,1,0,1
part b: upamostat 200/400 mg,0,0,0,1,0,1
partially hla-matched sars-covsts,0,0,0,1,0,1
participate in a massive musical event,0,1,0,0,0,1
particle measurement,0,1,0,0,0,1
passive microwave radiometry,0,1,0,0,0,1
"patch, nicotine",0,1,0,0,0,1
"patch, placebo",0,1,0,0,0,1
patient-centred advice on telephone consultation in tb patients:,0,0,0,1,0,1
patient educational video,0,0,1,0,0,1
patient mychart scheduling link,0,0,1,0,0,1
patient status engine,0,0,0,1,0,1
patients covid 19,0,0,0,1,0,1
pbmt,0,1,0,0,0,1
pbmt/smf,0,1,0,0,0,1
pcr/serology,0,0,0,1,0,1
pdno,0,0,0,1,0,1
peer presence,0,1,0,0,0,1
peer resilience champion,1,0,0,0,0,1
peginterferon beta-1a,0,1,0,0,0,1
peginterferon beta-1a prefilled syringe,0,0,0,1,0,1
pembrolizumab,0,0,0,1,0,1
pemziviptadil (pb1046),0,0,0,0,1,1
pentaglobin,0,0,0,1,0,1
pentoxifylline,0,1,0,0,0,1
pep flute,1,0,0,0,0,1
performance evaluation,0,0,0,1,0,1
performance evaluation (sensitivity,0,0,0,1,0,1
performance evaluation (sensitivity/specificity) for covid-19 diagnosis of the vocus ptr-tof process,0,0,0,1,0,1
performance of the test antigenic,0,1,0,0,0,1
performance of the test antigenic/test rt-pcr,0,1,0,0,0,1
performing of lung ultrasound,0,0,0,1,0,1
periogard,0,0,0,0,1,1
peripheral venous ultrasound,0,0,0,1,0,1
peroxyl,0,0,0,0,1,1
personal freedom message,0,1,0,0,0,1
personal protective equipment,0,0,0,1,0,1
personal protective equipment (ppe),0,1,0,0,0,1
personal protective measures,0,1,0,0,0,1
personal risk messaging,0,0,1,0,0,1
personalized feedback,0,1,0,0,0,1
personalized health education,0,0,0,1,0,1
personalized text message delivery of information,0,0,0,1,0,1
petrolatum ointment,0,1,0,0,0,1
pf-07321332/ritonavir,0,0,0,1,0,1
pfizer,1,0,0,0,0,1
pfizer-biontech covid-19 vaccine,0,0,0,1,0,1
pfizer-biontech covid-19 vaccine (comirnaty),0,0,0,1,0,1
pfizer bnt162b2 covid-19 vaccine,0,0,0,1,0,1
phase-1: breath holding test,0,0,0,1,0,1
phase 1,0,0,0,1,0,1
phase 2,0,0,0,1,0,1
phase 2: 6-minute walk test (6mwt),0,0,0,1,0,1
philly vax sweepstakes,1,0,0,0,0,1
phn intervention,0,1,0,0,0,1
phone-call screening,0,1,0,0,0,1
phone-call screening/management by a medical student/general practitioner tandem,0,1,0,0,0,1
phosphate-buffered saline,0,0,0,1,0,1
photobiomodulation,1,0,0,0,0,1
photobiomodulation/photodynamic therapy,1,0,0,0,0,1
phr160 spray,0,0,0,1,0,1
physical,0,1,0,0,0,1
physical activity counseling,0,0,0,1,0,1
physical examination,0,0,0,1,0,1
physical exercise/computerized cognitive training,1,0,0,0,0,1
physical therapy that include a standardized cycling training with functional electrical stimulation,0,0,0,1,0,1
physical therapy that include a standardized cycling training with no additional functional electrical stimulation,0,0,0,1,0,1
physical/cognitive activity,0,1,0,0,0,1
physiological effects of awake prone position in covid 19 patients,0,1,0,0,0,1
physiological irrigating solution,0,1,0,0,0,1
phytomedicine,0,0,1,0,0,1
piclidenoson,0,0,0,1,0,1
pioglitazone,0,1,0,0,0,1
pioglitazone 30 mg,0,0,0,1,0,1
pioglitazone 45 mg,0,0,0,1,0,1
piperacillin,0,0,0,1,0,1
piperacillin/tazobactam,0,0,0,1,0,1
pk test,0,0,0,1,0,1
placebo-lde phase 2,0,0,0,1,0,1
placebo-simulation of transcranial direct current stimulation,0,0,0,1,0,1
placebo - phase i,1,0,0,0,0,1
placebo (crossover vaccination period),1,0,0,0,0,1
placebo (im),0,0,0,1,0,1
placebo (inhaled solution),0,0,0,1,0,1
placebo (initial vaccination period),1,0,0,0,0,1
placebo (iv),0,0,0,1,0,1
placebo (methylcellulose) capsule,0,0,0,1,0,1
placebo (oral tablet),0,0,0,1,0,1
placebo (potato starch,0,0,0,1,0,1
placebo (potato starch/magnesium stearate),0,0,0,1,0,1
placebo (saline),0,1,0,0,0,1
placebo (sc injections),0,0,0,1,0,1
"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1,0,0,0,0,1
placebo (stage a),0,0,0,1,0,1
placebo (standard therapy),0,0,0,1,0,1
"placebo (two doses), priming",1,0,0,0,0,1
placebo / soc,0,0,0,0,1,1
placebo / standard of care (soc),0,0,0,1,0,1
placebo / vitamin d,0,0,0,1,0,1
placebo 0.9% nacl solution,0,0,0,1,0,1
placebo 1,0,1,0,0,0,1
placebo 2,0,1,0,0,0,1
placebo atazanavir,0,0,0,1,0,1
placebo booster,1,0,0,0,0,1
placebo comparator (without active ingredient) for intramuscular injection,1,0,0,0,0,1
placebo control,0,0,1,0,0,1
placebo control (non-behavioral infographic),0,1,0,0,0,1
placebo daclatasvir 60 mg,0,0,0,1,0,1
placebo empty capsule,0,0,0,1,0,1
placebo for abbv-2b04,0,1,0,0,0,1
placebo for abbv-47d11,0,1,0,0,0,1
placebo for camostat mesilate,0,0,0,1,0,1
placebo for inhalation,0,0,0,1,0,1
placebo for pf-07321332,0,0,0,1,0,1
placebo for ritonavir,0,0,0,1,0,1
placebo gel,0,0,0,1,0,1
placebo hydroxychloroquine,0,0,0,0,1,1
placebo inhaled,1,0,0,0,0,1
placebo inhaler,0,0,0,0,1,1
placebo injection/placebo pill,0,0,0,1,0,1
placebo iv,0,0,0,1,0,1
placebo magnesium,0,0,0,1,0,1
placebo mini drinks,0,0,0,1,0,1
placebo multiple,0,1,0,0,0,1
placebo nitazoxanide,0,0,0,0,1,1
placebo of fx06,0,1,0,0,0,1
placebo of nicotine transdermal patch,0,0,0,1,0,1
placebo oil,0,0,0,1,0,1
placebo oral solution,0,0,0,1,0,1
placebo patch,0,0,0,1,0,1
placebo pill,0,0,0,1,0,1
placebo ribavirin,0,0,0,0,1,1
placebo single,0,1,0,0,0,1
placebo sofusbuvir,0,0,0,1,0,1
placebo sofusbuvir / daclatasvir 60 mg,0,0,0,1,0,1
placebo taken po,0,1,0,0,0,1
placebo videos,0,1,0,0,0,1
placebo with remdesivir,0,0,0,1,0,1
placebo without radiofrequency.,0,0,0,1,0,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
placebo/control,0,0,0,1,0,1
plant stanol mini drinks,0,0,0,1,0,1
plasebo acupressure,0,0,1,0,0,1
plasma exchange/convalescent plasma,0,0,0,1,0,1
pln-74809,0,0,0,1,0,1
pneumococcal vaccine,1,0,0,0,0,1
pneumoniacheck,0,0,0,1,0,1
polio vaccine,0,0,1,0,0,1
polio vaccine/na-831,0,0,1,0,0,1
poly-iclc (hiltonolâ®),0,0,0,1,0,1
poly-iclc (hiltonolâ®)/placebo,0,0,0,1,0,1
polyester reusable mask,0,1,0,0,0,1
pop-up community vaccination sites,0,0,0,1,0,1
poractant alfa,0,0,0,1,0,1
position,0,0,0,1,0,1
positive feedback,0,1,0,0,0,1
positive psychotherapy,0,0,0,1,0,1
post-hospitalization nutritional monitoring,0,0,0,1,0,1
postpartum online self-directed program,0,0,0,1,0,1
postural positioning,0,0,0,1,0,1
power breathe,0,0,0,0,1,1
ppv23,0,1,0,0,0,1
ppv23 for the 2nd dose,0,1,0,0,0,1
prazosin,0,0,0,1,0,1
prediction market,0,1,0,0,0,1
prednisolone,0,0,0,1,0,1
prednisone tablet,0,0,0,1,0,1
preservision areds formulation soft gels,0,1,0,0,0,1
preservision areds formulation soft gels/tablets,0,1,0,0,0,1
press needles,0,0,0,1,0,1
primary care,0,1,0,0,0,1
primepro,0,1,0,0,0,1
pro-sero-cov,1,0,0,0,0,1
probiorinse,0,1,0,0,0,1
probiotics (2 strains 10x10^9 ufc),0,0,0,1,0,1
problem-solving,0,0,0,1,0,1
problem-solving/relationship improvement intervention.,0,0,0,1,0,1
problem solving therapy (pst).,0,0,0,1,0,1
procalcitonin,0,1,0,0,0,1
procalcitonin serum levels,0,1,0,0,0,1
produce prescription program,0,0,1,0,0,1
progesterone,0,1,0,0,0,1
progesterone 200 mg oral capsule,0,0,0,1,0,1
progressive cycling exercise test to exhaustion,0,1,0,0,0,1
progressive muscle relaxation,0,1,0,0,0,1
project echo,0,0,0,1,0,1
prolastin,0,1,0,0,0,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,0,1,0,0,0,1
prolonged proned positioning,0,1,0,0,0,1
promotores de salud,0,0,0,1,0,1
prone position (pp),0,0,0,1,0,1
prophylactic,0,1,0,0,0,1
prophylaxis,0,1,0,0,0,1
propofol,0,0,0,0,1,1
propolis,1,0,0,0,0,1
prosocial-benefit,0,0,1,0,0,1
prosocial acts,0,1,0,0,0,1
protect your elders campaign,0,0,0,1,0,1
protective ventilation,0,0,0,1,0,1
protein supplementation,1,0,0,0,0,1
prototype,0,0,0,1,0,1
proxalutamide (gt0918),0,0,0,1,0,1
"ps membrane versus pmma membrane,",1,0,0,0,0,1
psa value,0,0,0,1,0,1
psc-04,0,0,0,1,0,1
psg,0,1,0,0,0,1
psycho-education,0,1,0,0,0,1
psycho-education video,0,0,0,1,0,1
psychoeducation,1,0,0,0,0,1
psychological rehabilitation,0,0,0,1,0,1
psychological support,0,0,0,1,0,1
psychological triaging intervention,0,1,0,0,0,1
psychological/behaviour change support,0,0,0,1,0,1
psychotherapy,0,1,0,0,0,1
ptc299,0,0,0,1,0,1
ptx-covid19-b,1,0,0,0,0,1
public space exposure,0,1,0,0,0,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,1,0,0,0,0,1
pulmonary function testing,1,0,0,0,0,1
pulmonary physiotherapy techniques,0,1,0,0,0,1
pulmonary tele-rehabilitation,0,0,0,1,0,1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),0,0,0,1,0,1
pulse oximeter,1,0,0,0,0,1
pulse oximetry,0,1,0,0,0,1
purapo,0,0,0,1,0,1
purclo,0,0,0,1,0,1
purinf,0,0,0,1,0,1
purphl,0,0,0,1,0,1
purwet,0,0,0,1,0,1
pyridostigmine bromide,0,0,0,1,0,1
pyronaridine-artesunate (pa),0,0,0,1,0,1
qazcovac-p -covid-19 subunit vaccine,1,0,0,0,0,1
qniv nanoparticle vaccine2 in-clinic mixed with matrix-m1 adjuvant,0,0,0,1,0,1
qrt-pcr,0,0,1,0,0,1
qrt-pcr/serology,0,0,1,0,0,1
quadramune(tm),0,0,0,1,0,1
quadrivalent inactivated influenza high dose,0,0,0,1,0,1
qualitative,0,0,0,1,0,1
qualitative/quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quality of life promotion,1,0,0,0,0,1
quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quercetin phytosome,0,1,0,0,0,1
quercetin phytosome (qp),0,1,0,0,0,1
quidel sofia sars antigen fia,0,0,0,0,1,1
quinine,0,0,0,1,0,1
quinquina-stevia,0,0,1,0,0,1
quinquina-stevia/azythromycin,0,0,1,0,0,1
r tablets,1,0,0,0,0,1
race concordant,1,0,0,0,0,1
racial,1,0,0,0,0,1
racial inequality highlighted,0,1,0,0,0,1
racial/ethnic frame,1,0,0,0,0,1
rad26-s,0,0,0,1,0,1
radiofrequency therapy,0,0,0,1,0,1
radiological,0,0,0,1,0,1
radius ppg tetherless pulse oximetry (masimo),0,0,0,1,0,1
radx chcs testing intervention strategy,0,0,0,1,0,1
ramipril,0,0,0,1,0,1
randomized booster,1,0,0,0,0,1
rapa-501-allo off-the-shelf therapy of covid-19,0,0,0,1,0,1
rapid antigen test,0,1,0,0,0,1
rapid antigen testing,0,1,0,0,0,1
rapid antigen testing/offsite pcr testing,0,1,0,0,0,1
rapid antigen testing/onsite pcr testing,0,1,0,0,0,1
rapid nasopharyngeal antigen test for sars-cov-2,0,1,0,0,0,1
rapid salivary test,0,1,0,0,0,1
rayaldee 30mcg extended-release (er) capsule,1,0,0,0,0,1
razuprotafib subcutaneous solution,0,0,0,0,1,1
rbd-based protein subunit vaccine (zf2001) against covid-19,1,0,0,0,0,1
rbt-9 (90 mg),0,0,0,1,0,1
rdv,0,0,0,0,1,1
rdv placebo,0,0,0,1,0,1
read leaflets containing knowledge of covid-19,0,0,0,1,0,1
read leaflets containing knowledge of covid-19/vaccination.,0,0,0,1,0,1
reading a book,0,1,0,0,0,1
recharge,0,0,0,1,0,1
recombinant ad5 vectored covid-19 vaccine,1,0,0,0,0,1
recombinant covid-19 vaccine (sf9 cells),0,0,1,0,0,1
recombinant human annexin a5,0,0,0,1,0,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg,0,0,0,1,0,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),0,0,0,1,0,1
recombinant human plasma gelsolin (rhu-pgsn),1,0,0,0,0,1
recombinant ndv vectored vaccine for sars-cov-2,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) (ad5-ncov),0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.3ml,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.5ml,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) for inhalation,0,0,0,1,0,1
recombinant sars-cov-2 ad5 vectored vaccine,1,0,0,0,0,1
recombinant sars-cov-2 fusion protein vaccine,1,0,0,0,0,1
recombinant two-component covid-19 vaccine (cho cell),0,0,0,1,0,1
rectal swab,0,0,0,1,0,1
referral,0,0,0,1,0,1
referral card,0,0,0,1,0,1
referral/digital brochure,0,0,0,1,0,1
reframing,0,1,0,0,0,1
regeneron casirivimab,0,0,0,1,0,1
regeneron casirivimab / imdevimab,0,0,0,1,0,1
reginmune,0,1,0,0,0,1
regular care,0,1,0,0,0,1
rehabilitation,0,1,0,0,0,1
rehabilitation-focused program,0,0,0,1,0,1
rehabilitation by concentric exercises,0,0,0,1,0,1
rehabilitation by eccentric exercises,0,0,0,1,0,1
rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
rehabilitation programme,0,0,0,1,0,1
rehabilitation protocol through a digital platform,0,0,0,1,0,1
rejuveinix (rjx) active comparator,0,0,0,1,0,1
relationship improvement intervention.,0,0,0,1,0,1
relaxation,0,0,0,1,0,1
relaxation technique,0,1,0,0,0,1
remain covid free ssi,0,1,0,0,0,1
remdesivir-hu,1,0,0,0,0,1
remdesivir combination,0,0,0,1,0,1
remestemcel-l,1,0,0,0,0,1
remimazolam,0,0,0,1,0,1
remote cognitive behavioral therapy for insomnia,1,0,0,0,0,1
remote controlled exercise,0,0,0,1,0,1
remote problem management plus,0,0,0,1,0,1
"remote sms (short message service, also known as ""text message"") delivery",0,0,0,1,0,1
removal of dead space filter,0,1,0,0,0,1
renin-angiotensin system inhibitors,0,0,0,1,0,1
reprocessing recent traumatic event protocol,0,0,0,1,0,1
residence-based testing participation pilot (sars-cov-2 testing with relaxed social distancing restrictions),0,1,0,0,0,1
resilience program,1,0,0,0,0,1
resistance exercise,0,0,0,1,0,1
resistance training,0,0,1,0,0,1
resp-aer-meter,0,0,0,1,0,1
resp301,0,0,0,1,0,1
respiratory,0,0,0,1,0,1
respiratory function rehabilitation training,0,0,0,1,0,1
respiratory rehabilitation program (rr).,0,0,0,1,0,1
respiratory tele-rehabilitation program (trr).,0,0,0,1,0,1
respiratory tract sample,0,0,0,1,0,1
respiratory training,0,0,0,1,0,1
respiratory/psychological rehabilitation,0,0,0,1,0,1
resting 12 lead ecg,0,0,0,1,0,1
resting electrocardiogram,0,1,0,0,0,1
revised home-cov score,0,1,0,0,0,1
reward re-training,0,0,0,1,0,1
rh-dnase,0,0,0,1,0,1
rhace2,0,1,0,0,0,1
rhdnase i,0,0,0,1,0,1
rhinopharyngeal,0,1,0,0,0,1
rhtpo,0,0,0,1,0,1
ribaroxaban,0,1,0,0,0,1
rintatolimod,0,0,0,1,0,1
risankizumab,1,0,0,0,0,1
ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
ritonavir 50 mg [kaletra],1,0,0,0,0,1
ritonavir/oseltamivir,0,0,0,1,0,1
rivaroxaban 15mg tab,0,0,0,1,0,1
rnapc2,0,0,0,1,0,1
ro7496998,0,0,0,1,0,1
roactemra,0,0,0,0,1,1
robot assisted percutaneous cardiovascular intervention,0,0,0,1,0,1
robotic assisted early mobilization,0,0,0,1,0,1
robotic therapy,0,0,0,1,0,1
routine care (no sars-covsts),0,0,0,1,0,1
routine psychological support,0,1,0,0,0,1
rp7214,0,0,0,1,0,1
rp7214 / standard of care (soc),0,0,0,1,0,1
rph-104,0,1,0,0,0,1
rslv-132,0,0,0,1,0,1
rt-pcr sars-cov-2,1,0,0,0,0,1
rt-qpcr test,0,1,0,0,0,1
sab-185,1,0,0,0,0,1
"sab-185 (10,240 units",0,0,0,1,0,1
"sab-185 (10,240 units/kg)",0,0,0,1,0,1
"sab-185 (3,840 units",0,0,0,1,0,1
"sab-185 (3,840 units/kg)",0,0,0,1,0,1
sacubitril,0,0,0,1,0,1
sacubitril / valsartan oral tablet [entresto],0,0,0,1,0,1
saisei maf capsules,0,1,0,0,0,1
saline-sodium citrate (ssc) buffer,0,0,0,1,0,1
saline nasal,0,0,0,1,0,1
saline nasal spray,0,0,0,1,0,1
saline nasal/throat spray,0,0,0,1,0,1
saline placebo (double),0,0,0,1,0,1
saline placebo (single),0,0,0,1,0,1
saline placebo boost,0,0,0,1,0,1
saline with baby shampoo nasal irrigation,1,0,0,0,0,1
saline/standard care,0,1,0,0,0,1
saliva assay,0,1,0,0,0,1
saliva collected via salivette cortisol,0,1,0,0,0,1
saliva sample (self-sample),0,1,0,0,0,1
saliva sample/to an anterior nare self-swabbing (self-samples),0,1,0,0,0,1
saliva test kit,0,0,0,1,0,1
salivary sample,0,0,0,1,0,1
salivary test for covid19,1,0,0,0,0,1
sam-lnp-s,0,0,0,1,0,1
sam-lnp-s-tce,0,0,0,1,0,1
sample,0,0,0,1,0,1
sample collection,0,0,0,1,0,1
sample collection/performance evaluation (a),0,0,0,1,0,1
sample collection/performance evaluation (b),0,0,0,1,0,1
sampler skills,0,1,0,0,0,1
sampling,0,0,0,1,0,1
sampling by venipuncture (and eventually by nasopharyngeal swab),0,0,0,1,0,1
sampling of oropharynx,0,0,0,0,1,1
sampling of oropharynx/nasopharynx,0,0,0,0,1,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen,0,1,0,0,0,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen/saliva collected via salivette cortisol,0,1,0,0,0,1
sar443122,0,1,0,0,0,1
sarilumab prefilled syringe,0,0,0,1,0,1
sars-cov-2 adjuvanted recombinant protein vaccine (bivalent),0,0,0,1,0,1
sars-cov-2 adjuvanted recombinant protein vaccine (monovalent),0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614/b.1.351)-as03, dosage a",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614/b.1.351)-as03, dosage b",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 1",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 2",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 3",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 4",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03, dosage a",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03, dosage b",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (d614)-as03, dosage a",0,0,0,1,0,1
"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (d614)-as03, dosage b",0,0,0,1,0,1
sars-cov-2 antibody based ivig therapy,0,1,0,0,0,1
sars-cov-2 antibody test,1,0,0,0,0,1
sars-cov-2 antigen-specific cytotoxic t-lymphocytes,0,0,0,1,0,1
sars-cov-2 ig g levels,0,0,0,1,0,1
sars-cov-2 infection,1,0,0,0,0,1
sars-cov-2 mrna vaccine formulation 1,0,0,0,1,0,1
sars-cov-2 mrna vaccine formulation 2,0,0,0,1,0,1
sars-cov-2 mrna vaccine formulation 3,0,0,0,1,0,1
sars-cov-2 neutralizing antibody titer,0,0,0,1,0,1
sars-cov-2 recombinant protein vaccine phase 2 formulation 1,0,0,0,1,0,1
sars-cov-2 recombinant protein vaccine phase 2 formulation 2,0,0,0,1,0,1
sars-cov-2 recombinant protein vaccine phase 2 formulation 3,0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",0,0,0,1,0,1
sars-cov-2 rs nanoparticle vaccine in-clinic mixed with matrix-m1 adjuvant,0,0,0,1,0,1
sars-cov-2 rs/matrix-m adjuvant - phase 2,1,0,0,0,0,1
sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1,0,0,0,0,1
sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1,0,0,0,0,1
sars-cov-2 rs/matrix m1-adjuvant,1,0,0,0,0,1
sars-cov-2 rt-pcr assay for detection of covid-19 infection,0,0,0,1,0,1
sars-cov-2 screening by molecular biology,0,0,0,1,0,1
sars-cov-2 specific t cells,0,0,0,1,0,1
sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,0,1,0,0,0,1
sars-cov-2 vaccine,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 without adjuvant,1,0,0,0,0,1
sars-cov-2 viral composition,0,0,0,1,0,1
sars-cov-2 vlp vaccine,0,0,0,1,0,1
sars-cov-2 vlp vaccine-alpha (british) variant,0,0,0,1,0,1
sars-cov-2 vlp vaccine-wuhan,0,0,0,1,0,1
sars-cov-2 vlp vaccine-wuhan/alpha variant,0,0,0,1,0,1
sars-cov2 pfizer vaccine,0,0,0,1,0,1
sbi-101,0,0,0,1,0,1
sc-ad6-1,0,0,0,1,0,1
scarcity,0,1,0,0,0,1
scarcity message,0,1,0,0,0,1
scb-2019 with as03 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant/alum adjuvant,1,0,0,0,0,1
scd,0,1,0,0,0,1
sch intervention,0,0,1,0,0,1
screening blood test,1,0,0,0,0,1
sd biosensor,0,0,1,0,0,1
second dose,0,0,1,0,0,1
self-acupressure,0,0,0,1,0,1
self-benefit,0,0,1,0,0,1
self-care tools,0,1,0,0,0,1
"self-collected, home-based testing",0,0,1,0,0,1
self-compassion for chronic pain virtual group treatment program,0,0,0,1,0,1
self-focused acts,0,1,0,0,0,1
self-help booklet,0,1,0,0,0,1
self-help mindfulness,0,0,0,1,0,1
self-help mindfulness/compassion exercises,0,0,0,1,0,1
self-interest message,0,1,0,0,0,1
self-management booklet (switch: stay well during covid-19),1,0,0,0,0,1
self-questionnary,0,1,0,0,0,1
self measurement with pulse oximeter,0,0,0,1,0,1
self study,0,0,0,1,0,1
senicapoc,0,0,0,1,0,1
sentinox--group a,0,0,0,1,0,1
sentinox--group b,0,0,0,1,0,1
sequence of testing.,0,0,0,1,0,1
seraph,0,0,0,1,0,1
serological screening,0,0,0,1,0,1
serological testing for covid-19 infection,0,0,0,1,0,1
serological tests for sars cov-2,0,1,0,0,0,1
serology test follow-up,1,0,0,0,0,1
serology to determine sars-cov-2 infection,0,1,0,0,0,1
serology/elispot test,0,0,0,1,0,1
serum,0,1,0,0,0,1
services as usual,0,0,0,1,0,1
sessions,1,0,0,0,0,1
severity of lung involvement with covid-19.,0,1,0,0,0,1
sf-12,0,1,0,0,0,1
sfc (5-ala,0,0,0,1,0,1
sfc),0,0,0,1,0,1
sham,0,0,0,1,0,1
sham acupressure group,0,0,0,1,0,1
sham inflation,0,0,0,1,0,1
sham transcranial direct-current stimulation,1,0,0,0,0,1
sham treatment,0,0,0,1,0,1
shanshamani vati plus,0,1,0,0,0,1
shared decision making,0,1,0,0,0,1
shen cao gan jiang tang (gan cao gan jiang tang with ginseng),0,0,0,1,0,1
shg,0,1,0,0,0,1
"shingrix (zoster vaccine recombinant, adjuvanted)",0,0,0,1,0,1
sildenafil,1,0,0,0,0,1
sildenafil citrate,0,0,0,1,0,1
simha kriya,0,1,0,0,0,1
simple cognitive task,0,1,0,0,0,1
simulation intervention,0,0,0,1,0,1
simvastatin,0,0,0,1,0,1
single high dose vitamin d,1,0,0,0,0,1
singstrong: strong lungs through song,0,0,0,1,0,1
sinopharm vaccine,0,0,0,1,0,1
sir1-365,0,0,0,1,0,1
sirukumab,0,1,0,0,0,1
sit-to-stand test,0,0,0,1,0,1
sit to stand test,0,0,0,1,0,1
sivomixx,0,0,0,1,0,1
sledd with a l-mod,0,0,0,1,0,1
sleepio,0,0,0,1,0,1
sm-ema,0,0,0,1,0,1
smell retraining,0,0,0,1,0,1
smell training,1,0,0,0,0,1
smf,0,1,0,0,0,1
smoflipid,0,0,0,1,0,1
smoliv,0,0,0,1,0,1
sms-based support,0,0,0,1,0,1
sms delivery of information,0,0,0,1,0,1
sms message support,0,1,0,0,0,1
soap,1,0,0,0,0,1
soap distributed but no activities of the hbcc project,1,0,0,0,0,1
soc / ifx-1,0,0,0,1,0,1
soc / intravenous famotidine,0,1,0,0,0,1
soc therapy,0,1,0,0,0,1
soc/15mg/kg eb05 iv,0,0,0,1,0,1
soc/placebo iv,0,0,0,1,0,1
social,0,0,0,1,0,1
social proof,0,1,0,0,0,1
socialization,1,0,0,0,0,1
sodium bicarbonate 150meq,0,0,0,1,0,1
sodium bicarbonate 150meq/l/d5w inj,0,0,0,1,0,1
sodium bicarbonate solution,1,0,0,0,0,1
sodium chloride,0,0,0,1,0,1
"sodium chloride, 0.9%",0,0,0,1,0,1
"sodium chloride, usp, for injection (0.9% nacl)",1,0,0,0,0,1
sodium pyruvate,0,0,0,1,0,1
sodium pyruvate nasal spray,0,0,0,1,0,1
sofosbuvir 400 mg,0,0,0,1,0,1
sofosbuvir 400 mg/daclatasvir 200mg,0,0,0,1,0,1
sofosbuvir ledipsavir,0,0,0,1,0,1
sofusbuvir,0,0,0,1,0,1
sofusbuvir / daclastavir 60 mg,0,0,0,1,0,1
solution-focused support program,0,0,0,1,0,1
sorbitol,0,0,0,1,0,1
soterix tavns model 0125-lte stimulator - active-active group,1,0,0,0,0,1
soterix tavns model 0125-lte stimulator - sham-active group,1,0,0,0,0,1
sotrovimab,0,0,0,1,0,1
sotrovimab (gen1),0,0,0,1,0,1
sotrovimab (gen2),0,0,0,1,0,1
spartan covid-19 platform,0,0,0,1,0,1
spartan covid-19 system,0,1,0,0,0,1
specific exercise rehabilitation treatment,0,0,0,1,0,1
specificity) for covid-19 diagnosis of the vocus ptr-tof process,0,0,0,1,0,1
specimens specific for the study,0,0,0,1,0,1
speed of processing training,0,0,0,1,0,1
sperm test,0,0,0,1,0,1
sphenopalatine ganglion block with local anesthetic,0,0,0,1,0,1
sphenopalatine ganglion block with placebo (isotone nacl),0,0,0,1,0,1
spike protein (s),0,1,0,0,0,1
spike protein (s)/the nucleocapsid (n) of sars-cov-2,0,1,0,0,0,1
spin-chat program,0,1,0,0,0,1
spirometry,0,0,0,1,0,1
spironolactone,0,0,0,1,0,1
spironolactone / dexamethasone,0,0,0,1,0,1
spironolactone 25 mg pillules oral use,0,0,0,1,0,1
sputnik light,1,0,0,0,0,1
sse educational intervention,0,1,0,0,0,1
st266,0,0,0,1,0,1
staff wellbeing centres,0,1,0,0,0,1
standard-of-care sars-cov-2 treatment,0,0,0,1,0,1
standard care/monitoring,0,0,0,1,0,1
standard care/placebo,0,0,0,1,0,1
standard charity resources,1,0,0,0,0,1
standard enteral nutrition,0,0,0,1,0,1
standard guidelines,0,1,0,0,0,1
standard interface,0,1,0,0,0,1
standard message,0,1,0,0,0,1
standard of care (soc)/colchicine/rosuvastatin,0,0,0,1,0,1
standard of care for covid-19 as per the hospital guidelines,0,1,0,0,0,1
standard of care non-helmet based cpap ventilation,0,0,0,1,0,1
standard of care thromboprophylaxis,0,0,0,1,0,1
standard of care_1,0,1,0,0,0,1
standard of care_2,0,1,0,0,0,1
standard oxygen delivery system,0,1,0,0,0,1
standard prophylactic dose enoxaparin,0,1,0,0,0,1
standard prophylactic dose enoxaparin/ unfractionated heparin,0,1,0,0,0,1
"standard q covid-19 ag - test, produced by sd biosensor inc.",0,1,0,0,0,1
standard supportive treatment,0,0,0,1,0,1
standard therapy for covid-19 patient,0,1,0,0,0,1
standard therapy protocol (stp),1,0,0,0,0,1
standard treatment covid-19,0,0,0,1,0,1
standard treatment covid-19 / triazavirin,0,0,0,1,0,1
standard treatment of covid-19,0,0,0,1,0,1
standardized brazilian green propolis extract,0,0,0,1,0,1
stay connected,0,0,0,1,0,1
stc3141,0,0,0,1,0,1
steam inhalations,0,0,0,1,0,1
stellate ganglion block,0,0,0,1,0,1
sterile normal saline (0.9%),0,0,0,1,0,1
steroid,0,1,0,0,0,1
steroid taper (prednisone),0,1,0,0,0,1
steroid/anticoagulants according to different protocols.,0,1,0,0,0,1
sti-5656,0,0,0,1,0,1
stigma awareness video intervention,0,1,0,0,0,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,0,0,0,1,0,1
stool analysis,0,0,0,1,0,1
stools,0,0,0,1,0,1
stp,1,0,0,0,0,1
stp / covid-19 convalescent plasma (cp),1,0,0,0,0,1
stp / standard plasma (sp),1,0,0,0,0,1
strength rmt,0,0,0,1,0,1
strength rmt/nasal breathing,0,0,0,1,0,1
strengthening exercise,0,1,0,0,0,1
stress,0,0,0,1,0,1
stress first aid,0,0,0,1,0,1
stress test,0,1,0,0,0,1
stress/emotion management,0,0,0,1,0,1
striveweekly,0,0,1,0,0,1
student-senior isolation prevention partnership (ssipp),0,0,0,1,0,1
sublingual methylene blue,0,0,0,1,0,1
sublingual micro-dose ketamine,1,0,0,0,0,1
substance use disorders using prolonged exposure (cope),0,0,0,1,0,1
sudarshan kriya yoga (sky),1,0,0,0,0,1
sulfur hexafluoride lipid-type a microspheres,0,0,0,1,0,1
sulodexide,0,1,0,0,0,1
sun exposure,0,0,0,0,1,1
supervised rehabilitation program.,0,0,0,1,0,1
supervised stretching,0,1,0,0,0,1
supervised stretching/strengthening exercise,0,1,0,0,0,1
supine position,0,1,0,0,0,1
supine positioning,0,0,0,1,0,1
support,0,0,0,1,0,1
support as usual,0,0,0,1,0,1
supportive services,0,0,0,1,0,1
supportive services.,0,0,0,1,0,1
supportive therapy,0,0,0,1,0,1
supportive therapy ssi,0,1,0,0,0,1
supportive tratment,1,0,0,0,0,1
supportive/symptomatic treatment,1,0,0,0,0,1
surgical face mask use only,0,1,0,0,0,1
surgical facial mask,0,1,0,0,0,1
survey of acceptability of the different self-samples.,0,1,0,0,0,1
survey of sars-cov-19 knowledge,0,1,0,0,0,1
suspension,0,0,0,1,0,1
suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,0,0,0,1,0,1
swab,0,0,0,1,0,1
sweat samples (covidog ancillary study),1,0,0,0,0,1
symbicort,0,0,0,0,1,1
symptom survey,0,0,0,1,0,1
symptomatic drugs,0,0,0,1,0,1
symptomatic treatment,1,0,0,0,0,1
symptomatic treatment (paracetamol,0,0,0,1,0,1
symptomatic treatment (paracetamol),0,0,0,1,0,1
symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
synthetic mva-based sars-cov-2 vaccine coh04s1,0,0,0,1,0,1
synthetic neutralising antibodies,0,0,0,1,0,1
t-cell receptor,0,0,0,1,0,1
t cell derived exosom,1,0,0,0,0,1
t memory cells,0,0,0,1,0,1
t memory cells/nk cells,0,0,0,1,0,1
t regulatory cells,0,0,0,1,0,1
t3 solution,0,0,0,0,1,1
tab,0,0,0,1,0,1
tablets,0,1,0,0,0,1
tafenoquine oral tablet,0,0,0,1,0,1
tailored best practices,0,0,0,1,0,1
tailored information,0,0,0,1,0,1
tailored recommendations,0,0,0,1,0,1
tak-019,1,0,0,0,0,1
tak-919,1,0,0,0,0,1
tape-software,0,0,0,1,0,1
targeted message,0,0,0,1,0,1
tazobactam,0,0,0,1,0,1
tcc-covid mhealth,0,0,0,1,0,1
td139,1,0,0,0,0,1
technology based social interactions,0,1,0,0,0,1
telacebec,0,0,0,1,0,1
tele-delivered psychological intervention,0,0,0,1,0,1
tele-exergaming tablet,0,0,0,1,0,1
tele-interventions related to diabetes management,0,1,0,0,0,1
tele-interventions related to diabetes management/mental well-being,0,1,0,0,0,1
telegeriatric intervention,0,1,0,0,0,1
telehealth monitoring,1,0,0,0,0,1
telehealth/counselling,1,0,0,0,0,1
telemedicine visit,0,0,0,1,0,1
telemonitoring,0,0,0,1,0,1
telemonitoring/teleorientation,0,0,0,1,0,1
teleorientation/tooth brushing orientation,0,0,0,1,0,1
telephone follow-up,0,1,0,0,0,1
telepsychoeducation,0,0,1,0,0,1
telepsychoeducation with personalized videos,0,0,1,0,0,1
telepsychoeducation without personalized videos,0,0,1,0,0,1
telerehabilitation-based relaxation exercise group (eg),0,0,0,1,0,1
telesimulation,1,0,0,0,0,1
telestroke,0,1,0,0,0,1
telmisartan 20mg oral tablet,0,0,0,1,0,1
telmisartan 40mg oral tablet,0,0,0,1,0,1
telmisartan oral product,0,0,0,1,0,1
tempol,0,0,0,1,0,1
tenecteplase,0,0,1,0,0,1
tenofovir,0,1,0,0,0,1
tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],0,0,0,1,0,1
tenofovir disoproxil/emtricitabine,0,1,0,0,0,1
tenofovir disoproxyl fumarate 300 mg,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg oral tablet,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg/emtricitabine 200 mg oral tablet,0,0,0,1,0,1
tensile strength,0,1,0,0,0,1
test group: experimental - uvc therapy applied,1,0,0,0,0,1
test rt-pcr,0,1,0,0,0,1
testing,0,0,0,1,0,1
testing for sars-cov-2 igm,0,0,0,1,0,1
testing for sars-cov-2 igm/igg,0,0,0,1,0,1
testing for sars-cov-2 rna,0,0,0,1,0,1
testis pathology samples,0,0,0,1,0,1
tetracycline hydrochloride 3%,0,1,0,0,0,1
tetrandrine,0,0,1,0,0,1
text material for psychoeducation,0,0,0,1,0,1
text material for psychoeducation/audio for relaxation techniques,0,0,0,1,0,1
the management of severe covid-19 cases,1,0,0,0,0,1
the nucleocapsid (n) of sars-cov-2,0,1,0,0,0,1
the psychosocial effects of covid-19 pandemic on dental professionals,0,1,0,0,0,1
the sars-cov-2 inactivated vaccine,0,0,0,1,0,1
the standard protocol only,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
theophylline powder,0,0,0,1,0,1
theory-based messages,0,1,0,0,0,1
therapeutic exercise,0,0,1,0,0,1
therapeutic exercise/education,0,0,1,0,0,1
therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3),0,0,0,1,0,1
theraputic heparin,0,0,0,1,0,1
therapy intervention,0,1,0,0,0,1
three dose regimen,0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1,0,0,0,0,1
three doses of high dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1,0,0,0,0,1
three doses of high dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1,0,0,0,0,1
three doses of medium dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1,0,0,0,0,1
three doses of medium dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1,0,0,0,0,1
"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
three doses of placebo at the emergency vaccination schedule,1,0,0,0,0,1
three doses of placebo at the routine vaccination schedule,1,0,0,0,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",0,0,0,1,0,1
throat,0,0,0,1,0,1
throat spray,0,0,0,1,0,1
throat swab,0,0,0,1,0,1
thymic peptides,0,1,0,0,0,1
thymosin,0,0,0,1,0,1
tigeraseâ®,0,1,0,0,0,1
tigeraseâ®/best available care,0,1,0,0,0,1
"tinzaparin, high dose prophylactic anticoagulation",0,0,0,1,0,1
"tinzaparin, low dose prophylactic anticoagulation",0,0,0,1,0,1
"tinzaparin,therapeutic anticoagulation",0,0,0,1,0,1
tirofiban,0,1,0,0,0,1
tj003234,0,0,0,1,0,1
tl-895,0,1,0,0,0,1
tm5614,0,0,0,1,0,1
tnkase,0,0,0,1,0,1
to an anterior nare self-swabbing (self-samples),0,1,0,0,0,1
to be given as a treatment,0,0,0,1,0,1
to monitor the effectiveness of the single dose ad26.cov2.s covid-19 vaccine,0,0,0,1,0,1
tociliuzumab,0,1,0,0,0,1
tociliziumab group,1,0,0,0,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,0,0,0,0,1,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),0,0,0,0,1,1
tooth brushing orientation,0,0,0,1,0,1
toothpaste with sodium fluoride,0,0,1,0,0,1
toothpaste with sodium fluoride/zinc,0,0,1,0,0,1
toothpaste with sodium monofluorophosphate,0,0,1,0,0,1
toothpaste with tin fluoride,0,0,1,0,0,1
tozinameran,0,0,0,1,0,1
tpa,0,1,0,0,0,1
tq formula,0,0,0,1,0,1
tq formula/tab,0,0,0,1,0,1
tr,0,0,0,1,0,1
tracheotomy,0,1,0,0,0,1
tradipitant,0,0,1,0,0,1
traditional chinese medicine,0,0,0,1,0,1
traditional proning arm,0,1,0,0,0,1
training,0,1,0,0,0,1
training clinicians in basic critical care,1,0,0,0,0,1
training clinicians in basic critical care/the management of severe covid-19 cases,1,0,0,0,0,1
"training for awareness, resilience,",0,1,0,0,0,1
"training for awareness, resilience,/action (tara)",0,1,0,0,0,1
"training of youth, community health assistants",1,0,0,0,0,1
"training of youth, community health assistants/community health workers.",1,0,0,0,0,1
training session adressing information,0,0,0,1,0,1
training session adressing information/health literacy,0,0,0,1,0,1
tranexamic acid,0,0,0,0,1,1
trans sodium crocetinate,0,0,0,1,0,1
transcendental meditation,0,1,0,0,0,1
transcranial direct-current stimulation,1,0,0,0,0,1
transcutaneous auricular vagus nerve stimulation,0,1,0,0,0,1
transfer package from ci therapy,0,0,0,1,0,1
transfusion of sars-cov-2 convalescent plasma.,0,0,0,1,0,1
transfusion of standard plasma.,0,0,0,1,0,1
transpulmonary pressure measurements,0,0,0,1,0,1
trauma-informed yoga video recording,0,1,0,0,0,1
trauma informed psychotherapy,0,1,0,0,0,1
trauma informed yoga,0,1,0,0,0,1
travelan otc,1,0,0,0,0,1
treadmill exercise,0,0,0,1,0,1
treamid,0,1,0,0,0,1
treated with hyperimmune plasma,0,0,0,1,0,1
treatment,0,1,0,0,0,1
treatment as usual,0,0,0,1,0,1
treatment as usual vitamin d,1,0,0,0,0,1
treatment/prophylaxis,0,1,0,0,0,1
trial-based cognitive therapy,0,0,0,1,0,1
triazavirin,0,0,0,1,0,1
triazavirin (riamilovir),0,0,0,1,0,1
tridecactide,0,1,0,0,0,1
trimetazidine,0,0,0,1,0,1
trimodulin,1,0,0,0,0,1
trimoxazole,0,0,0,1,0,1
trivalent split influenza vaccine,1,0,0,0,0,1
trust in science message,0,1,0,0,0,1
tsu,0,0,0,1,0,1
tsvf,0,0,0,1,0,1
turcovac,0,0,0,1,0,1
two covid-19 vaccine candidate (tmv-083,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083/v-591) administrations - high dose,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083/v-591) administrations - low dose,0,1,0,0,0,1
two dose chadox1 ncov-19,1,0,0,0,0,1
two dose chadox1 ncov-19/covishield 0.25ml/0.5ml,1,0,0,0,0,1
two dose chadox1 ncov-19/covishield 0.5ml,1,0,0,0,0,1
two dose menacwy vaccine min. 4 weeks apart,1,0,0,0,0,1
two dose regimen,0,0,0,1,0,1
two doses of bnt162b2 vaccine,1,0,0,0,0,1
"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,1,0,0,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28",0,1,0,0,0,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28/one dose quadrivalent influenza vaccine on day 0/day 28.",0,1,0,0,0,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28/one dose quadrivalent influenza vaccine on day 14.",0,1,0,0,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,1,0,0,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",0,1,0,0,0,1
"two doses of placebo at the schedule of day 0, 14 #high-dose group#",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",0,0,0,1,0,1
uexplorer,0,0,0,1,0,1
uexplorer/mct,0,0,0,1,0,1
ultra-micronized palmitoylethanolamide (mpea,0,1,0,0,0,1
ultra brief online mindfulness-based intervention,0,1,0,0,0,1
ultraprotective ventilation,0,0,0,1,0,1
umifenovir,0,0,1,0,0,1
"umpea, 300mg",0,1,0,0,0,1
unavailable covid test result - hypothetical scenario,0,1,0,0,0,1
unfractionated heparin iv,0,0,0,1,0,1
unfractionated heparin sc,0,0,0,1,0,1
uni911 inhalation 1%,0,1,0,0,0,1
uni911 inhalation 1%/intranasal spray 1%,0,1,0,0,0,1
unified protocol for covid-19 parenting stress (up-covid),0,1,0,0,0,1
unsupervised physical activities,0,0,0,1,0,1
upper limb training,0,0,0,1,0,1
uptake of covid-19 testing,0,0,0,1,0,1
urine pregnancy test for women of childbearing potential,0,0,0,1,0,1
urine samples,1,0,0,0,0,1
usability,0,1,0,0,0,1
usb002,0,0,0,1,0,1
use of facetime with child,0,0,0,1,0,1
use of facetime with child/parents during induction,0,0,0,1,0,1
usual antibiotic treatment,0,1,0,0,0,1
usual care control,0,0,0,1,0,1
usual care only,0,0,0,1,0,1
usual care positioning with no instructions,0,0,0,0,1,1
usual care treatment,0,1,0,0,0,1
"usual care, infection control briefing",0,0,0,1,0,1
usual monitoring,0,0,0,1,0,1
usual orientations,0,0,0,1,0,1
usual practice / symbicort rapihaler,0,0,0,0,1,1
usual treatments in intensive care unit according to the current state of knowledge,0,0,0,1,0,1
utooth btc),0,0,0,1,0,1
uttr1147a,0,1,0,0,0,1
uv light treatment,0,1,0,0,0,1
v-591) administration - high dose,0,1,0,0,0,1
v-591) administrations - high dose,0,1,0,0,0,1
v-591) administrations - low dose,0,1,0,0,0,1
v-sars,1,0,0,0,0,1
v hydrogen peroxide,0,0,0,1,0,1
v povidone-iodide,0,0,0,1,0,1
v) saline,1,0,0,0,0,1
v590,0,0,0,0,1,1
v591,0,0,0,0,1,1
vaccinated with polio vaccine (ipv),1,0,0,0,0,1
vaccination,0,0,0,1,0,1
vaccination against covid19,0,0,0,1,0,1
vaccination.,0,0,0,1,0,1
vaccine for intramuscular injection,1,0,0,0,0,1
vaccine therapy,0,0,0,1,0,1
vaccine: bnt162b2 10mcg,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
vadadustat,0,0,0,1,0,1
valsartan oral tablet [entresto],0,0,0,1,0,1
varespladib,0,0,0,1,0,1
vas scale,0,0,0,1,0,1
vaxzevria,0,0,0,1,0,1
vb-201,0,0,0,1,0,1
vb-201 / standard of care,0,0,0,1,0,1
vbi-2902a,1,0,0,0,0,1
vcpm,0,1,0,0,0,1
vehicle,0,1,0,0,0,1
vehicle / heparin along with best supportive care,0,1,0,0,0,1
vehicle control,0,1,0,0,0,1
venous blood collection,0,1,0,0,0,1
venous draw,0,0,0,1,0,1
venous draw/testing,0,0,0,1,0,1
venous ultrasound of lower extremity,0,0,0,1,0,1
ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),0,1,0,0,0,1
verapamil,0,1,0,0,0,1
vesta respirator,0,0,0,1,0,1
vib7734,0,0,0,0,1,1
vibrolung,0,0,0,1,0,1
video-based intervention,0,0,0,1,0,1
video-based psychotherapy,0,1,0,0,0,1
video chat,0,1,0,0,0,1
video chat / basic feedback,0,1,0,0,0,1
video chat /personalized feedback,0,1,0,0,0,1
video dance classes,0,0,0,1,0,1
vielight rx plus,1,0,0,0,0,1
vir-7832,0,0,0,1,0,1
viral vector vaccine booster,1,0,0,0,0,1
virazole,0,1,0,0,0,1
virgin coconut oil,0,0,0,1,0,1
virgin coconut oil (vco),0,0,0,1,0,1
virtual-care cognitive behavioural therapy,0,0,0,1,0,1
"virtual assistant first, then human coach",0,0,0,1,0,1
virtual care at home,0,0,0,1,0,1
virtual elm,0,1,0,0,0,1
virtual family-based treatment,0,0,1,0,0,1
virtual group exercise,1,0,0,0,0,1
virtual group intervention,0,1,0,0,0,1
virtual individual cognitive simulation therapy,0,0,0,1,0,1
virtual reality,0,1,0,0,0,1
virtual reality therapy first,1,0,0,0,0,1
viruxal oral,0,0,0,1,0,1
viruxal oral/nasal spray,0,0,0,1,0,1
vit-d 0.2 mg,0,1,0,0,0,1
vit-d 0.2 mg/ml oral solution [calcidol],0,1,0,0,0,1
vital signs,0,0,0,1,0,1
vitamin a,0,0,0,1,0,1
vitamin b,0,0,0,1,0,1
vitamin c 500 mg oral tablet,0,0,0,1,0,1
vitamin c tablets,0,0,0,1,0,1
"vitamin c, vitamin b complex",1,0,0,0,0,1
"vitamin c, vitamin b complex/zinc acetate",1,0,0,0,0,1
vitamin c/zinc,0,0,0,1,0,1
vitamin d (cholecalciferol),0,0,0,1,0,1
vitamin d3 (cholecalciferol),0,0,0,1,0,1
"vitamin d3 50,000 iu",0,0,0,1,0,1
vitamin d3/placebo,1,0,0,0,0,1
vitamin e,0,1,0,0,0,1
vitamin k2,0,0,0,1,0,1
vitamin k2 in the form of menaquinone-7 (mk-7),0,0,0,1,0,1
vitamin k2/d,0,0,0,1,0,1
vitamine d3 supplementation,0,0,0,0,1,1
vitamins,0,0,0,1,0,1
vla2101,0,0,0,1,0,1
voclosporin,0,0,0,1,0,1
volatile organic compounds analysis (e-noses),0,0,0,1,0,1
volatile organic compounds analysis (mass spectrometry),0,0,0,1,0,1
volatile organic compounds analysis in sweat (mass spectrometry),0,0,0,1,0,1
vortioxetine,0,0,0,1,0,1
vr for psychoeducation,0,0,0,1,0,1
vr for psychoeducation/relaxation,0,0,0,1,0,1
vv-ecmo,0,1,0,0,0,1
vv-ecmo / cytokine adsorption,0,1,0,0,0,1
vxa-cov2-1,1,0,0,0,0,1
walk test,0,0,0,1,0,1
ward css,0,0,0,1,0,1
water (e) mouth rinse with the solution provided,0,0,0,1,0,1
water without an elevated level of kelea,0,0,0,1,0,1
wearing surgical face mask sprayed with hypertonic saline,0,0,0,1,0,1
webex physical activity program,0,0,0,1,0,1
weekly assessment,0,0,0,0,1,1
wellness education,0,1,0,0,0,1
wfi water nebulization,0,0,0,1,0,1
wharton's jelly derived mesenchymal stem cells.,0,0,0,1,0,1
white sender in acknowledgement,0,1,0,0,0,1
white sender in informational videos,0,1,0,0,0,1
who recommendations (waiting condition),0,0,0,1,0,1
who score,1,0,0,0,0,1
wingate exercise test,0,0,0,1,0,1
wingate exercise test/on-ice testing while wearing a face mask,0,0,0,1,0,1
wingate exercise test/on-ice testing while wearing a sham face mask,0,0,0,1,0,1
withings scanwatch,0,0,0,1,0,1
woebot substance use disorder,0,1,0,0,0,1
wofb,0,0,0,1,0,1
women sexual dysfunctions were screened using female sexual functioning index (fsfi),0,1,0,0,0,1
written summary of rounds,0,1,0,0,0,1
xagrotin,0,1,0,0,0,1
xc7 100 mg single,0,1,0,0,0,1
xc7 200 mg multiple,0,1,0,0,0,1
xc7 200 mg single,0,1,0,0,0,1
xcel-umc-beta,0,0,0,1,0,1
"xiamen wiz biotech co., ltd. sars-cov-2 antigen rapid test",0,1,0,0,0,1
xlear nasal spray,0,0,0,1,0,1
xuanfei baidu granules,0,0,0,1,0,1
xvr011,0,0,0,1,0,1
xylitol,0,0,0,1,0,1
yoga group,0,1,0,0,0,1
zanubrutinib,0,1,0,0,0,1
zavegepant (bhv-3500),0,0,0,1,0,1
zidovudine,0,1,0,0,0,1
zilucoplan,0,1,0,0,0,1
zilucoplan placebo,0,1,0,0,0,1
zinc (zinc gluconate),0,0,0,1,0,1
zinc (zinc gluconate)/vitamin d (cholecalciferol),0,0,0,1,0,1
zinc citrate,0,0,0,1,0,1
zinc picolinate,1,0,0,0,0,1
zinc sulfate 220 mg,0,1,0,0,0,1
zithromax,0,0,0,1,0,1
zn,0,0,0,1,0,1
zofin,0,0,0,1,0,1
zotatifin,0,0,0,1,0,1
